US20140213661A1 - Hydrophilic interpenetrating polymer networks derived from hydrophobic polymers - Google Patents
Hydrophilic interpenetrating polymer networks derived from hydrophobic polymers Download PDFInfo
- Publication number
- US20140213661A1 US20140213661A1 US14/243,843 US201414243843A US2014213661A1 US 20140213661 A1 US20140213661 A1 US 20140213661A1 US 201414243843 A US201414243843 A US 201414243843A US 2014213661 A1 US2014213661 A1 US 2014213661A1
- Authority
- US
- United States
- Prior art keywords
- polyurethane
- hydrogel
- implant device
- orthopedic implant
- polymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/26—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/80—Preparations for artificial teeth, for filling teeth or for capping teeth
- A61K6/884—Preparations for artificial teeth, for filling teeth or for capping teeth comprising natural or synthetic resins
- A61K6/891—Compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- A61K6/893—Polyurethanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
- A61L27/48—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with macromolecular fillers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/56—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F283/00—Macromolecular compounds obtained by polymerising monomers on to polymers provided for in subclass C08G
- C08F283/02—Macromolecular compounds obtained by polymerising monomers on to polymers provided for in subclass C08G on to polycarbonates or saturated polyesters
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
- C08G18/67—Unsaturated compounds having active hydrogen
- C08G18/671—Unsaturated compounds having only one group containing active hydrogen
- C08G18/672—Esters of acrylic or alkyl acrylic acid having only one group containing active hydrogen
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
- C08J9/36—After-treatment
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L75/00—Compositions of polyureas or polyurethanes; Compositions of derivatives of such polymers
- C08L75/04—Polyurethanes
- C08L75/14—Polyurethanes having carbon-to-carbon unsaturated bonds
- C08L75/16—Polyurethanes having carbon-to-carbon unsaturated bonds having terminal carbon-to-carbon unsaturated bonds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B37/00—Methods or apparatus for laminating, e.g. by curing or by ultrasonic bonding
- B32B37/14—Methods or apparatus for laminating, e.g. by curing or by ultrasonic bonding characterised by the properties of the layers
- B32B37/24—Methods or apparatus for laminating, e.g. by curing or by ultrasonic bonding characterised by the properties of the layers with at least one layer not being coherent before laminating, e.g. made up from granular material sprinkled onto a substrate
- B32B2037/243—Coating
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B2375/00—Polyureas; Polyurethanes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B2535/00—Medical equipment, e.g. bandage, prostheses, catheter
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G2210/00—Compositions for preparing hydrogels
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G2270/00—Compositions for creating interpenetrating networks
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2375/00—Characterised by the use of polyureas or polyurethanes; Derivatives of such polymers
- C08J2375/04—Polyurethanes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/31504—Composite [nonstructural laminate]
- Y10T428/31551—Of polyamidoester [polyurethane, polyisocyanate, polycarbamate, etc.]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/31504—Composite [nonstructural laminate]
- Y10T428/31551—Of polyamidoester [polyurethane, polyisocyanate, polycarbamate, etc.]
- Y10T428/31573—Next to addition polymer of ethylenically unsaturated monomer
- Y10T428/31583—Nitrile monomer type [polyacrylonitrile, etc.]
Definitions
- the present invention relates generally to polymers, and more specifically to methods by which hydrogel and polyurethane polymers are grafted together to form two-layered structures, and by which they are attached to bone, in ways that are useful for medical and commercial devices.
- the invention also includes materials and articles formed by this method.
- Hydrogels have been combined with polyurethanes to form articles with certain useful properties. Hydrogel materials have been reinforced with polyurethanes and other materials to provide a more robust backing material. Also, a hydrogel coating or overlayer can be added to a hydrophobic polymer article to improve the article's biocompatibility. Prior hydrogel/polyurethane combinations have not provided the best combination of strength and swellability, however. In addition, prior methods of making hydrogel/polyurethane combinations have used expensive and/or toxic processes.
- Hoffman et al. U.S. Pat. No. 3,826,678 describes a process for coating an inert polymeric substrate with a reactable hydrogel polymer and then attaching a biologically active molecule in order to make a biocompatible material with a biofunctional surface.
- Hoffman's “radiation grafting” refers to application of expensive high energy to a polymer, a treatment that causes both non-specific formation of bonds and non-specific breaking of bonds. The bonds made are non-specific bonds between the two polymers anywhere along the backbone of the chains, as well as non-specific bonds (“crosslinking”) within each polymer.
- Conditions for using “radiation grafting” were chosen by Hoffman such that more favorable than unfavorable reactions occur.
- Yang et al. J. Biomed Mater Res 45:133-139, 1999 describe a process for forming a graft material having both polyurethane and hydrogel.
- Yang formed a mixture of polyurethane, acrylic acid, and photoinitiator, and treated it with UV light in the absence of a degassing step to create an homogeneous and unlayered acrylic acid/polyurethane polymer grafted throughout its composition.
- Wang et al. (U.S. Patent Publication 2002/00524480) describe a process for forming a material having a modified surface that can be used to tether other compounds at the surface while maintaining the bulk properties of the material.
- Wang started with a formed hydrophobic polymer, such as an acylic or polyurethane, and introduced a functional monomer such as acylate or vinyl monomer, and an initiator just at the polymer surface, such as by limited swelling of the polymer in a solvent.
- the functional monomer was treated, such as with UV irradiation, to form a second polymer.
- a surface modification agent, such as heparin may be attached to the second polymer.
- IPN Interpenetrating Polymer Network
- Gao et al. (Chinese Journal of Polymer Science Vol. 19, No. 5, (2001), 493-498) describe improvements to materials for use in improving long-term implants that become integrated into the body, such as devices put into blood vessels and in artificial hearts.
- Gao describes two methods to create on a segmented polyurethane a hydrophilic surface containing functional groups that will adhere cells and support growth. In both methods, the segmented polyurethane was activated by a high concentration of toxic hydrogen peroxide (30%) and UV light to generate reactive groups.
- the activated segmented polyurethane was immersed in a solution of hydrophilic monomers, such as 2-(dimethylamino)ethyl methacrylate, 2-hydroxyethyl acrylate or acrylamide, and ammonium iron (II) sulfate hexahydrate, and the monomers grafted onto the segmented polyurethane by treatment with UV light.
- hydrophilic monomers such as 2-(dimethylamino)ethyl methacrylate, 2-hydroxyethyl acrylate or acrylamide, and ammonium iron (II) sulfate hexahydrate
- the activated segmented polyurethane membrane was immersed in a solution of hydrophilic monomers, removed, placed under nitrogen, and the hydrophilic monomers grafted onto the reactive groups of the segmented polyurethane by treatment with UV light.
- the membrane was rinsed with hot water for 48 hours to remove homopolymers.
- the result was a very thin layer of hydrophilic polymer coating on the surface of the polyurethane.
- SEM images of materials made using the “Solution Grafting Method” versus those made using “Pre-Absorbing Grafting Method” show significant differences in appearance in materials made using the different methods.
- the present invention improves upon prior articles made from a combination of a hydrogel and a polyurethane and methods of making such articles.
- the mechanical properties desired for certain medical applications is often outside the range of possibility of many hydrophilic starting materials.
- one aspect of this invention takes advantage of the high mechanical strength of hydrophobic starting materials and combines those materials with hydrogels as a useful way to achieve the goal of high mechanical strength in addition to other desirable properties provided by the hydrogels without the cost and issues associated with the use of highly specialized equipment (e.g., 60 Co radiation source) or damage to and/or ambiguity about the composition of the formed material due to lack of specificity in the treatment to effect bonding (e.g., gamma irradiation).
- highly specialized equipment e.g. 60 Co radiation source
- damage to and/or ambiguity about the composition of the formed material due to lack of specificity in the treatment to effect bonding e.g., gamma irradiation.
- an “interpenetrating polymer network” or “IPN” is a material comprising two or more polymer networks which are at least partially interlaced on a molecular scale, but not covalently bonded to each other, and cannot be separated unless chemical bonds are broken.
- a “polymer” is a substance comprising macromolecules (comprising repeated units of monomers), including homopolymers and copolymers.
- a “copolymer” is a polymer derived from two or more species of monomer.
- a “homopolymer” is a polymer derived from a single monomeric species.
- a “graft polymer” is a polymer of that has side chains (“graft macromolecules”) containing different atoms from those in the main chain. This definition includes side chains that are polymers.
- a “graft copolymer” is a graft polymer in which adjacent blocks in the main (or in the side) chains comprise different species of monomer.
- One aspect of the invention provides an article having a hydrogel layer chemically grafted to an end-functionalized polyurethane layer.
- the hydrogel and polyurethane are interfacially grafted.
- the polyurethane layer may be selected from a group consisting of polycarbonate urethane, polycarbonate urethane urea, polyester urethane, polyether urethane, polyurethane urea, or a silicone derivative of these.
- the polyurethane may have hard segments, soft segments, chain extenders, and end groups.
- the hard segments are selected from the group 1,5 naphthalene diisocyanate (NDI), isophorone isocyanate (IPDI), 3,3-bitoluene diisocyanate (TODI), methylene bis(p-cyclohexyl isocyanate) (H12MDI), cyclohexyl diiscocyanate (CHDI), 2,6 tolulene diisocyanate or 2,4 toluene diisocyanate (TDI), hexamethyl diisocyanate (HMDI), and methylene bis(p-phenyl isocyanate) (MDI).
- NDI naphthalene diisocyanate
- IPDI isophorone isocyanate
- TODI 3,3-bitoluene diisocyanate
- H12MDI methylene bis(p-cyclohexyl isocyan
- the soft segments of the polyurethane may be selected from the group hydroxy terminated butadiene, hydroxyl terminated polyisobutylene, hydroxybutyl terminated polydimethylsiloxane (PDMS), poly (1,6 hexyl 1,2-ethyl carbonate), hydrogenated polybutadiene, polycaprolactone, polyethylene adipate, polyethylene oxide (PEO), polyhexamethylene carbonate glycol, polypropylene oxide (PPO), polytetramethylene adipate, and poly(tetramethylene oxide) (PTMO).
- the chain extenders of the polyurethane may be selected from the group 1,4 butanediol, ethylenediamine, 4,4′methylene bis(2-chloroaniline) (MOCA), ethylene glycol, and hexane diol.
- the polyurethane endgroups may be selected from the group acylamide, acrylate, allyl ether, methacrylate, or vinyl.
- the hydrogel layer may be end-linked macromeric subunits, e.g. PEG or a biomolecule, or polymerized monomeric subunits.
- the biomolecule may be, e.g., collagen, one or more growth factors, steroids, bisphosphonates, or combinations or derivatives thereof.
- the biomolecules may be selected from the group any Bone Morphogenetic Protein, any Fibroblast Growth Factor, any Transforming Growth Factor, or any Osteogenic Protein.
- the hydrogel layer may be a homopolymer. In some embodiments the hydrogel may be polymerized monomeric subunits. In some embodiments, the hydrogel layer may be a copolymer. The copolymer may have a polymerized subunit, such as a subunit selected from the group consisting of acrylamide, hydroxyethyl acrylamide, N-isopropyl acrylamide, 2-hydroxyethyl methacrylate, and 2-hydroxyethyl acrylate. In some embodiments, the hydrogel network may contain at least 50%, at least 75%, or at least 90% by dry weight of telechelic macromonomer.
- the hydrogel layer may be an IPN with a first and second network.
- the first IPN network may be end-linked macromeric subunits.
- the polymerized macromeric subunits may be selected from the group consisting of PEG, poly(N-vinyl pyrrolidone), polydimethylsiloxane, poly (vinyl alcohol), polysaccharide, and a biomolecule.
- the polymerized macromeric subunits may have end group or side group functionalities selected from the group consisting of acrylamide, acrylate, allyl, methacrylamide, methacrylate, N-vinyl sulfone, and vinyl.
- the second IPN network may be polymerized subunits (monomers).
- the subunits may be hydrophilic.
- the hydrophilic subunit may be ionizable.
- the ionizable subunit may be anionic.
- the anionic subunits may include carboxylic acid and/or sulfonic acid groups.
- the second network may be polyacrylic acid.
- the ionizable subunit may be cationic.
- the hydrophilic subunit may be non-ionic.
- the non-ionic subunit may be selected from the group consisting of acrylamide, methacrylamide, N-hydroxyethyl acrylamide, N-isopropylacrylamide, methyl methacrylate, N-vinyl pyrrolidone, 2-hydroxyethyl methacrylate, 2-hydroxyethyl acrylate, and/or derivatives of these.
- both networks of the IPN may be grafted to the polyurethane.
- a second polyurethane may be attached to the first polyurethane.
- the second polyurethane may have functionalized end groups.
- the second polyurethane may include salt such as salt with crystals of size that varies from 100 ⁇ m to 1000 ⁇ m.
- the second polyurethane may be porous, with the pore size varying, e.g.; from 10 ⁇ m to 1000 ⁇ m .
- the second polyurethane may contain foaming agents to create open cell porosity, with the pore size varying, e.g.; from 10 ⁇ m to 1000 ⁇ m.
- the second polyurethane may include a biomolecule.
- the biomolecule may be selected from the group consisting of collagen, bone morphogenetic protein, bisphosphonate, and an osteogenic protein.
- the second polyurethane may include a bone component, i.e., a material normally found in natural bone.
- the bone component may be one or more of carbonated apatite, hydroxyapatite, alpha tricalcium phosphate, beta tricalcium phosphate, and other calcium phosphates.
- the second polyurethane may include entrapped fillers.
- the second polyurethane may include an antioxidant.
- the antioxidant may be selected from the group consisting of ascorbic acid, beta carotene, glutathione, Irganox®, lipoic acid, retinol, santowhite, uric acid, ubiquinol, and Vitamin E.
- Another aspect of the invention provides an article having a first polyurethane, and a second polyurethane attached to the first polyurethane, the second polyurethane having a putty-like hardness.
- the second polyurethane has reactive end groups.
- the second polyurethane may include salt.
- the second polyurethane may be porous.
- the composition of the first and second polyurethane may include entrapped fillers.
- the composition of the first and second polyurethane may include an antioxidant.
- the antioxidant may be selected from the group consisting of ascorbic acid, Vitamin E, Irganox, santowhite, glutathione, uric acid, lipoic acid, beta carotene, retinol, and ubiquinol.
- Another aspect of the invention provides a process for grafting a polyurethane to a hydrogel including the following steps: freezing a first solution containing either reactive hydrogel precursors or end-functionalized polyurethane precursors; applying a second solution containing either end-functionalized polyurethane precursors or reactive hydrogel precursors to the first solution; and polymerizing and crosslinking the solutions to form a laminated graft polymer having a polyurethane and a hydrogel.
- Another aspect of the invention provides a process for grafting a polyurethane to a hydrogel including the following steps: casting a layer from a solution containing end-functionalized polyurethane precursors; applying a second solution containing reactive hydrogel precursors, the second solution containing a solvent for the polyurethane layer; and polymerizing and crosslinking the solutions to form a laminated graft polymer having a polyurethane and a hydrogel.
- the polymerizing step uses UV light or heat.
- the method may include the steps of immersing at least part of the laminated graft polymer in a third solution; the third solution having hydrogel precursors different from the precursors in the first or second solutions; swelling the graft polymer; and polymerizing the third solution to create a graft polymer having a polyurethane and an IPN, whereby the IPN has a second hydrogel network intertwined with a first hydrogel network.
- the third solution may be a partial solvent for the first hydrogel, and is able to swell the first hydrogel network.
- the solution containing the hydrogel precursors may have telechelic molecules.
- the telechelic molecules may be poly(ethylene) glycol with one or more endgroups selected from the group consisting of acrylate, methacrylate, acrylamide, vinyl, or allyl ether.
- the polyurethane solution may have one or more materials selected from the group consisting of vinyl terminated polyurethane, polycarbonate urethane, polyether urethane, polycarbonate urethane urea, polyester urethane, polyurethane urea and silicone derivatives of these.
- Another aspect of the invention provides a process for making a material that can be attached to bone, including the following steps: applying a solution that contains a polyurethane precursor having reactive endgroups, and further containing solvent, photoinitiator and crosslinker to a first polyurethane that is grafted to a hydrogel; polymerizing the polyurethane precursor; and treating with heat and convection to remove the solvent to yield a second unreacted telechelic polyurethane surface coated on a polyurethane grafted hydrogel.
- the second polyurethane may be polycarbonate urethane and in others polyether urethane.
- the reactive endgroups may be selected from the group consisting of acrylamide, acrylate, allyl ether, methacrylate, and vinyl.
- the solvent may be selected from the group consisting of dimethylacetamide, dimethyl sulfoxide, and tetrahydrofuran.
- the applying step includes applying a salt.
- Another aspect of the invention provides a process for attaching an article to a bone, the article including a porous polyurethane having a photointiator and a crosslinker, the method including the steps of placing the porous polyurethane in apposition to the bone; and polymerizing the second polyurethane to attach the article to the bone.
- the porous polyurethane contacts and flows into the bone.
- the article may also include a second polyurethane attached to the porous polyurethane and optionally a hydrogel.
- the polymerizing step may include exposing the polyurethane to UV light, heat, or a chemical initiator.
- the polyurethane-grafted hydrogels of the present invention have numerous applications in medicine and industry. In orthopaedics, there is a great need for cartilage replacement materials that emulate the properties of natural cartilage. The invention may also be useful in other areas of orthopaedics (in any joint), such as the spine, a disc or facet replacement, or as a bursal replacement. Other applications of the polyurethane-grafted hydrogels are possible, in fields including but not limited to wound care (e.g. as a wound dressing), plastic surgery, urology (e.g. catheters), or cardiology (e.g. as a stent, catheter, or valve material).
- wound care e.g. as a wound dressing
- plastic surgery e.g. catheters
- cardiology e.g. as a stent, catheter, or valve material
- the polyurethane-grafted hydrogels are useful as devices in the form of plugs, patches, caps, or cups to repair defects in joint surfaces.
- a device is comprised of a hydrogel bearing side and a porous polyurethane bone-interface side which are chemically bonded to each other.
- the hydrogel side provides a lubricious, “cartilage-like” bearing surface while the polyurethane side provides structural reinforcement and facilitates bone adhesion and ingrowth.
- the bone interface side of the polyurethane-grafted hydrogel is adhered to bone through any of the above mentioned approaches.
- FIGS. 1A-C illustrate a process by which hydrogels and polyurethanes are grafted according to one aspect of this invention.
- FIGS. 2A-B illustrate one example of a polyethylene glycol (PEG)-dimethacrylate hydrogel grafted to a methacrylate functionalized polyurethane to yield a polyurethane grafted PEG hydrogel.
- PEG polyethylene glycol
- FIGS. 3A-C illustrate how an IPN is formed and grafted to a polyurethane.
- FIGS. 4A-B illustrate how a double polymer graft is formed between polyurethane and a hydrogel IPN.
- FIGS. 5A-C illustrate how a telechelic polyurethane adhesive is deposited on a polyurethane backing layer.
- FIGS. 6A-B shows examples of the polyurethane backing material and polyurethane adhesive.
- FIGS. 7A-D illustrate how the adhesive polyurethane attaches a material to bone according to one aspect of this invention
- FIGS. 8A-B illustrate how the graft copolymer attaches to bone.
- FIGS. 9A-C illustrate how an osteochondral graft implant formed from a polymer graft of this invention can be used to replace or augment cartilage within a joint.
- FIG. 10 is a shows a photomicrograph of a cross-section of the polyurethane-grafted hydrogel of a material made according to one aspect of this invention.
- FIG. 11 shows the results of testing the static material properties of a material of the current invention.
- FIG. 12 shows the results of lap shear testing to determine the strength of material made according to the current invention.
- FIGS. 13A-C illustrate the integration of osteocondral grafts and other implants of this invention into bone over time.
- a polyurethane is interfacially grafted to a hydrogel to create a layered strong, lubricious polymer graft material.
- monomers or macromonomers of a hydrogel precursor are dissolved with photoinitiator and, optionally, a crosslinker, in an organic solvent or buffer.
- monomers or macromonomers of a second hydrogel precursor that will form a copolymer are also dissolved.
- biomolecules may be added.
- Monomers or macromonomers of a polyurethane precursor are also dissolved along with photoinitator, and optionally a crosslinker, in an organic solvent or buffer; the organic solvent or buffer can be the same or different composition as the one in which the hydrogel precursors are dissolved.
- Additional materials that will give the materials additional properties (“additives”) can be added to either or both solutions.
- the additives can be the same or different in the two solutions.
- Any type of organic solvent can be used to create the solutions of the monomers and macromonomers, such as dimethylacetamide, dimethyl sulfoxide, tetrahydrofuran, or chloroform.
- photoinitiator includes, but is not limited to, 2-hydroxy-2-methyl-propiophenone and 2-hydroxy-1-[4-(2-hydroxyethoxy) phenyl]-2-methyl-1-propanone.
- any type of compatible cross-linkers may be used to crosslink the second network m the presence of any of the aforementioned first networks such as, for example, ethylene glycol dimethacrylate, ethylene glycol diacrylate, diethylene glycol dimethacrylate (or diacrylate), triethylene glycol dimethacrylate (or diacrylate), tetraethylene glycol dimethacrylate (or diacrylate), polyethylene glycol dimethacrylate, or polyethylene glycol diacrylate, methylene bisacrylamide, N,N′-(1,2-dihydroxyethylene)bisacrylamide, derivatives, or combinations thereof.
- first networks such as, for example, ethylene glycol dimethacrylate, ethylene glycol diacrylate, diethylene glycol dimethacrylate (or diacrylate), triethylene glycol dimethacrylate (or diacrylate), tetraethylene glycol dimethacrylate (or diacrylate), polyethylene glycol dimethacrylate, or polyethylene glycol diacrylate, methylene bisacrylamide,
- any monomer or macromonomer may be used to form the polyurethane layer.
- the polyurethane has reactive ends. Either one or both ends of the polyurethane may be functionalized. Examples of materials that can be used are polymers having surface active endgroups. See, e.g., Ward et al, U.S. Pat. No. 5,589,563.
- biomolecules e.g., collagen, growth factors (any Bone Morphogenetic Proteins (BMPs)), Fibroblast Growth Factors (FGFs), Transforming Growth Factors (e.g., TGFB), Osteogenic Proteins (e.g., OP-1 or osteopontin), steroids (e.g., dexamethasone), and bisphosphonates
- BMPs Bone Morphogenetic Proteins
- FGFs Fibroblast Growth Factors
- FGFs Fibroblast Growth Factors
- TGFB Transforming Growth Factors
- Osteogenic Proteins e.g., OP-1 or osteopontin
- steroids e.g., dexamethasone
- bisphosphonates may be incorporated either as an additive or by covalent linkages, combinations, and/or derivatives thereof.
- Bone components may also be incorporated into the device, such as hydroxyapatite, carbonated apatite, alpha tricalcium phosphate, beta tricalcium
- the hydrogel precursor solution containing initiator is cast over a mold and flash-frozen in, for example, a liquid nitrogen bath.
- the polyurethane precursor solution containing initiator is then cast over the surface of the solidified hydrogel precursor solution.
- the polyurethane precursor solution can be, for example, at room temperature or below. Freezing the first set of precursors before adding the second set prevents major mixing of the two sets of precursors. Polymerization and cross linking is then initiated by UV or heat.
- the polyurethane precursor solution containing initiator is cast over a mold and flash-frozen in, for example, a liquid nitrogen bath.
- the hydrogel precursor solution containing initiator is then cast over the surface of the solidified polyurethane precursor solution.
- the hydrogel precursor solution can be, for example, at room temperature or below. Polymerization and cross linking is then initiated by UV or heat.
- the polyurethane precursor solution (e.g., in dimethylacetamide or tetrahydrofuran), is cast over a mold and dried (e.g., at room temperature), to form a layer.
- the hydrogel precursor solution containing at least in part a solvent for the polyurethane layer (e.g., dimethylacetamide or tetrahydrofuran), is applied on the surface of the polyurethane layer. Polymerization and cross linking is initiated by UV or heat.
- FIGS. 1A-C shows a graft polymer having a polyurethane polymer grafted to a hydrogel polymer, and the method of making, according to the current invention.
- FIG. 1A shows two layers of polymer precursors before polymerization.
- One precursor layer is frozen (e.g., using a liquid nitrogen bath) or otherwise solidified (e.g., by drying) and then a second precursor layer is added to the solidified layer.
- the figure shows one layer of telechelic hydrogel precursors 2 with functional endgroups 4 and 6 .
- the telechelic ends can be the same or different structures.
- the figure shows a second layer of telechelic polyurethane precursors 8 with hard segments 10 and soft segments 12 .
- the functional groups, 14 and 16 on the ends of the polyurethane precursor can be the same or different structures.
- the “bottom” (solidified) layer comprises either set of precursors, and the “top” layer comprises the other set.
- the telechelic polyurethane precursors 8 may be frozen.
- the hydrogel precursors 2 may be frozen.
- the layered solutions are covered with a glass plate and polymerized through free radical polymerization, using, for example, exposure to UV light 26 . Exposure to UV light is thought to have two effects: (1) it initiates polymerization and crosslinking of the two precursor solutions, and (2) it melts at least some of the frozen hydrogel or telechelic polyurethane precursor layer, providing chain mobility at the interface between the two layers, and allowing grafting of the hydrogel to the polyurethane at the interface between the two layers.
- the process of polymerization may generate additional heat that melts the bulk of the frozen layer, allowing the layer to polymerize and crosslink.
- Polymerization leads to the formation of a polyurethane grafted hydrogel material 24 , as shown in FIG. 1B .
- the hydrogel polymer 18 is covalently bound by a graft 22 to the polyurethane polymer 20 .
- the hard segments of the polyurethane polymer 20 assemble to form hard phases 26 , as shown in the graft polymer 29 in FIG. 1C .
- the soft segments assemble in soft phases 28 .
- the use of an end-functionalized polyurethane precursor enables the hydrogel layer to graft to the polyurethane layer using relatively inexpensive UV polymerization while minimizing the amount of initiator (such as hydrogen peroxide) used to facilitate grafting.
- hydrogel polymer network Any monomer or macromonomer or biomacromolecule may be used to form the hydrogel polymer network.
- the hydrogel polymer network will be referred to as the “first” network and the polyurethane polymer network as the “second” network; but it should be understood that either solution can be solidified (e.g., frozen or dried) first.
- preformed polyethylene glycol (PEG) macromonomers can be used as the basis of the hydrogel polymer network.
- PEG is biocompatible, soluble in aqueous solution, and can be synthesized to give a wide range of molecular weights and chemical structures.
- the hydroxyl end-groups of the bifunctional glycol can be modified into crosslinkable/polymerizeable end-groups to form telechelic PEG molecules with vinyl endgroups such as acrylate, methacrylate, acrylamide, methyacrylamide, vinyl, or allyl ether.
- FIGS. 2A-B show a particular example of a graft polymer having a polyurethane polymer grafted to a hydrogel polymer.
- FIG. 2A shows a poly(ethylene glycol) 100 having reactive dimethylacrylate endgroups 104 being polymerized and crosslinked in the presence of a polyurethane 102 having reactive methacrylate endgroups 106 .
- the result is a polyurethane-grafted PEG hydrogel 111 having a network hydrogel polymer 110 attached via a covalent linkage 114 to a functionalized polyurethane 112 .
- the solvent used can be water or an organic solvent, (e.g., dimethylacetamide or tetrahydrofuran).
- poly(ethylene glycol) in addition to the poly(ethylene glycol), other macromonomers such as polycarbonate, poly(N-vinyl pyrrolidone), polydimethylsiloxane, poly(vinyl alcohol), polysacchrarides (e.g., dextran), biomacromolecules (e.g., collagen) and derivatives or combinations thereof can also be chemically modified with endgroup or side-group functionalities such as acrylates, methacrylates, allyl ethers, vinyls, acrylamides, and methacrylamides and used to form the hydrogel polymer network.
- endgroup or side-group functionalities such as acrylates, methacrylates, allyl ethers, vinyls, acrylamides, and methacrylamides and used to form the hydrogel polymer network.
- the first network can also be copolymerize with any number of other polymers including but not limited to those based on acrylamide, hydroxyethyl acrylamide, N-isopropylacrylamide, 2-hydroxyethyl methacrylate, 2-hydroxyethyl acrylate or derivatives thereof.
- the polymerized subunit may be a derivative of an acrylate, methacrylate, vinyl, allyl ether, or acrylamide monomer.
- the dry weight of the first polymer network is at least 50%, more preferably at least 75% by weight, and most preferably at least 95% telechelic macromonomer.
- the polyurethane polymer of the second network can be a commercially available material or it can be a new material, including but not limited to a polycarbonate urethane, polycarbonate urethane urea, polyether urethane, segmented polyurethane urea, silicone polycarbonate urethane, or silicone polyether urethane.
- the molecular weight of the second polymer layer is high enough to provide structural stability to the material.
- the polyurethane precursor can be vinyl-terminated (on one or both ends) polyurethane, polycarbonate urethane, polycarbonate urethane ureas, polyester urethane, polyether urethane, polyurethane urea, as well as silicone derivatives of these or combinations thereof.
- Isocyanates that are used to generate the hard segment include 1,5 naphthalene diisocyanate (NDI), isophorone isocyanate (IPDI), 3,3-bitoluene diisocyanate (TODI), methylene bis(p-cyclohexyl isocyanate) (H12MDI), cyclohexyl diiscocyanate (CHDI), 2,6 tolylene diisocyanate or 2,4 toluene diisocyanate (TDI), hexamethyl diisocyanate, or methylene bis(p-phenyl isocyanate).
- NDI 1,5 naphthalene diisocyanate
- IPDI isophorone isocyanate
- TODI 3,3-bitoluene diisocyanate
- H12MDI methylene bis(p-cyclohexyl isocyanate)
- CHDI cyclohexyl diiscocyanate
- TDI 2,6
- Chemicals that may be used to generated the soft segment include hydroxy terminated butadiene, hydroxyl terminate polyisobutylene, hydroxybutyl terminated polydimethylsiloxane (PDMS), poly (1,6 hexyl 1,2-ethyl carbonate, and hydrogenated polybutadiene, polycaprolactone, polyethylene adipate, polyethylene oxide (PEO), polyhexamethylene carbonate glycol, polypropylene oxide (PPO), polytetramethylene adipate, and poly(tetramethylene oxide) (PTMO).
- Chain extenders include 1,4 butanediol, ethylene diamine, 4,4′methylene bis(2-chloroaniline) (MOCA), ethylene glycol, and hexane diol.
- MOCA 4,4′methylene bis(2-chloroaniline)
- the groups that are used to functionalize the polyurethane macromonomers can be chosen from the same group listed above to functionalize the hydrogel macromoners (e.g., acrylamides, acrylates, allyl ethers, methacrylamides, methacrylates, and vinyls).
- the functional groups can be on one or both ends, and they can be the same groups or different groups.
- Free radical polymerization of the above process may be initiated by other means, such as thermal-initiation and other chemistries not involving the use of ultraviolet light.
- additives can be incorporated into the materials on either the hydrogel side or the polyurethane side. These additives can be included as entrapped fillers or as covalently attached molecules or particles.
- anti-oxidants can be covalently linked into the hydrogel by methacryloxy-functionalization of the anti-oxidant.
- a methacrylate group can be regioselectively attached to the primary hydroxyl group of L-ascorbic acid (Vitamin C) by reaction of 2,2,2 trifluoromethyl methacrylate with an immobilized lipase enzyme from Candida Antarctica at 60 degrees Celsius in dioxane in the presence of a polymerization inhibitor (e.g.
- hydroquinone or di-tert-butyl methyl phenol hydroquinone or di-tert-butyl methyl phenol.
- Other anti-oxidants can be added, including but not limited to beta carotene, glutathione, Irganox®, lipoic acid, retinol, santowhite, ubiquinol, uric acid, or Vitamin E).
- a second hydrogel network can be added to the first hydrogel network by swelling the hydrogel grafted polyurethane or the first hydrogel network portion of the hydrogel grafted polyurethane in a second solution containing hydrogel precursors with initiator.
- the second solution may act as a partial solvent for the hydrogel network to swell it without dissolving.
- the precursors of the second hydrogel network are polymerized inside the first hydrogel network. The result is an interpenetrating polymer network (1PN) grafted to a polyurethane.
- FIGS. 3A-C show an embodiment of a graft polymer having a polyurethane grafted interpenetrating polymer network hydrogel.
- FIG. 3A shows a polyurethane grafted hydrogel 24 having a polyurethane polymer 20 grafted to a single hydrogel network 18 via graft linkage 22 .
- the polyurethane polymer 20 has hard phases 26 and soft phases 28 .
- the polymer graft is swollen in a solution of a second hydrogel precursor 30 as shown in FIG. 3B , along with optional crosslinker and photoinitiator (not shown).
- the second hydrogel precursor 30 is polymerized, as by UV light 36 , to form a second hydrogel network 34 interpenetrated within a first hydrogel network 18 as shown in FIG. 3C .
- the final result is a polyurethane-grafted interpenetrating polymer network hydrogel 32 .
- a second hydrogel network can be added to the first hydrogel network.
- the hydrogel grafted polyurethane is swollen in a second solution containing hydrogel precursors with optional crosslinker and photoinitiator.
- the second solution may act as a partial solvent for the hydrogel network.
- the precursors of the second hydrogel network are polymerized and crosslinked inside the first hydrogel network to yield a polymer graft, with both hydrogels of the interpenetrating polymer network grafted to polyurethane.
- the polyurethane second network that is grafted to the first hydrogel network has available reactive groups, such as excess isocyanate.
- FIGS. 4A-B show an example of a double graft polymer having a polyurethane polymer grafted to two networks of a hydrogel IPN.
- FIG. 4A shows a first hydrogel network 124 crosslinked 136 to a polyurethane 130 which has excess functional groups 132 such as isocyanate.
- the first hydrogel network 124 is entangled with a second hydrogel network 126 forming a hydrogel IPN 120 .
- the second hydrogel network 126 has functional groups 128 such as carboxylate.
- the functional group 128 of the second hydrogel network interacts with the reactive group 132 of the polyurethane to form a bond 134 , and yield a double polymer graft 122 , as shown in FIG. 4 .
- the hydrophilic precursor in the second hydrogel network is ionizable and anionic (capable of being negatively charged) to yield an ionizable second hydrogel network.
- the ionizable second hydrogel polymer network can be poly(acrylic acid) (PAA) hydrogel formed from an aqueous solution of acrylic acid monomers.
- PAA poly(acrylic acid)
- Other ionizable monomers include ones that contain negatively charged carboxylic acid or sulfonic acid groups, such as 2-acrylamido-2-methylpropanesulfonic acid, methacrylic acid, hyaluronic acid, heparin sulfate, chondroitin sulfate, and derivatives, or combinations thereof.
- the second hydrogel network monomer may also be positively charged or cationic.
- the hydrophilic precursor for the second hydrogel polymer network may also be non-ionic, such as acrylamide, methacrylamide, N-hydroxyethyl acrylamide, N-isopropylacrylamide, methylmethacrylate, N-vinyl pyrrolidone, 2-hydroxyethyl methacrylate, 2-hydroxyethyl acrylate or derivatives thereof.
- these can be copolymerized with ionizable monomers, or with less hydrophilic species such as methylmethacrylate or other more hydrophobic monomers or macromonomers.
- Crosslinked linear polymer chains i.e., macromolecules
- these monomers may also be used in the second network, as well as biomacromolecules such as proteins and polypeptides (e.g., collagen, hyaluronic acid, or chitosan).
- biomacromolecules such as proteins and polypeptides (e.g., collagen, hyaluronic acid, or chitosan).
- a telechelic polyurethane with photoreactive endgroups in an organic solvent with photoinitiator and crosslinker is coated onto a polyurethane.
- the solvent is removed under heat (e.g., 35 degrees Celsius) and convection for about 24-72 hours to yield a putty-like layer of end-linkable polyurethane layered on top of a preexisting polyurethane.
- Coating an existing polyurethane layer in this fashion effectively bonds the two materials together through packing of the hard segments of the two polyurethanes, effectively creating a single body.
- the putty is then pressed into a prepared surface of bone and the polyurethane exposed to a stimulus, such as
- UV light to induce polymerization and crosslinking. This leads to mechanical interlocking of the polyurethane within the pores of the bone.
- the polyurethane is polycarbonate urethane or polyether urethane.
- the photoreactive endgroups on the polyurethane may be acrylamide, acrylate, allyl ether, methacrylate, or vinyl.
- the organic solvent may be dimethylacetamide, dimethyl sulfoxide, or tetrahydrofuran or combinations of these.
- the polyurethane may comprise a copolymer comprising linking monomers.
- the linking monomers may include acrylamide, dimethyl acrylamide, HEMA, triethylene glycol dimethacrylate, methyl methacrylate, and hydroxy ethyl acrylate (HEA).
- the linking monomers may improve the strength of the putty.
- salts are incorporated into the bone contacting layer. Any type of salt may be used. After incorporation of the putty into the bone and over time, the salts may be dissolved (e.g., NaCl) by body fluids or resorbed (e.g., tricalcium phosphate or carbonated apatite) by the body.
- the polyurethane may be attached to a hydrogel, such as described above.
- thermal, chemical-initiated or other methods of causing polymerization may be used to polymerize and crosslink the putty that has been pressed into a prepared surface of bone.
- FIGS. 5A-C show how a telechelic adhesive polyurethane is deposited onto a first polyurethane.
- the adhesive polyurethane can be osteoconductive and/or porous.
- FIG. 5A shows an adhesive telechelic polyurethane precursor 38 having hard segments 40 , a soft segment 42 , and functional endgroups 44 and 46 .
- the endgroups 44 and 46 of the telechelic polyurethane can be the same or different structures.
- the telechelic polyurethane precursor can be a macromonomer with functional endgroups having any number of repeats “n” of the hard and soft segments as shown.
- FIG. 5A shows an adhesive telechelic polyurethane precursor 38 having hard segments 40 , a soft segment 42 , and functional endgroups 44 and 46 .
- the endgroups 44 and 46 of the telechelic polyurethane can be the same or different structures.
- the telechelic polyurethane precursor can be
- FIG. 5A also shows a material 50 with a polyurethane backing layer 52 , and optionally a hydrogel layer 54 bonded to the polyurethane backing layer.
- the material 50 can be in the shape of a device such as for orthopedic use.
- the polyurethane precursors 38 can be coated onto the surface of the material 50 to form an unreacted putty layer 70 on the polyurethane 52 with the putty layer and the backing layer held together by crystallization of the hard segments to create a single body 68 , as shown in FIG. 5B .
- the putty layer is cured by treatment with UV light 74 and removal of solvent 76 , to form a reacted adhesive 80 as shown in FIG. 5C .
- salt 78 can be included in the reacted adhesive.
- the salt causes the material to be osteoconductive, or, after its removal, to form pores which allows for ingrowth of new bone.
- a foaming agent may be added to the polyurethane precursor solution or the second polyurethane to create open cell porosity.
- the porosity may vary in size, e.g., from about 10 ⁇ m to about 1000 ⁇ m.
- the solvent is removed prior to the UV curing step. In another embodiment, the solvent is removed after the UV curing step.
- thermal, chemical-initiated or other methods of effecting polymerization are used to coat the second polyurethane onto the first polyurethane-backed hydrogel following the process above.
- the reactive group of the second, telechelic polyurethane can be an acrylamide, acrylate, allyl ether, methacrylate, or vinyl group.
- FIG. 6A-B show examples of materials that can be used in the present invention.
- FIG. 6A shows the structure of Bionate® polycarbonate-urethane that can be used in a polyurethane grafted hydrogel such as those as described in FIGS. 1 and 3 , and as the backing material in FIG. 5 .
- FIG. 6B shows Bionate® polycarbonate-urethane with acrylate functionalized end-groups that can be used as the adhesive layer such as described in FIGS. 5A-C .
- the lowercase “m” and “n” indicate that the polyurethane can have any number of soft and hard segments.
- FIGS. 7A-C show a schematic of how a device can be attached to a bone using the polyurethane of the present invention.
- FIG. 7A shows a device, 200 , such as an orthopedic device, with a layer of polyurethane adhesive or putty 202 which contains salt 204 .
- the putty attached to the device is apposed to a prepared surface of bone 206 , and the putty 202 is made to interdigitate around the bone 206 , as shown in FIG. 7B .
- the putty cures around the bone 208 .
- the salt is removed, and pores 210 are left behind it its place. The pores provide a space for new bone growth 212 into the cured putty 208 as shown in FIG. 7D , thereby anchoring the device in place.
- therapeutic agents may also be incorporated into the putty, including but not limited to antibiotics and antimicrobials.
- a porous polyurethane is incorporated into the polyurethane backing layer of the present invention.
- This porous polyurethane can be incorporated by casting a salt-saturated (about 25%-90% by weight) solution of polyurethane in an organic solvent (about 10%-75% by weight) such as dimethylacetamide or dimethyl sulfoxide, evaporating the solvent under heat (e.g. 80° Celsius) and convection, and then washing the salt away in water.
- the salt can be any type of salt, including but not limited to sodium chloride or calcium phosphate or derivatives and/or combinations of these.
- the resulting porous backing layer can serve as a surface for attachment to bone using commercially available adhesives or cements (e.g., bone cements or dental cements) while also serving as a porous scaffold for bone ingrowth.
- biomolecules e.g., collagen, growth factors (such as Bone Morphogenetic Proteins (BMPs)), Fibroblast Growth Factors (FGFs), Transforming Growth Factors (e.g., TGFB), Osteogenic Proteins (e.g., OP-1 or osteopontin), steroids (e.g., dexamethasone), and bisphosphonates
- BMPs Bone Morphogenetic Proteins
- FGFs Fibroblast Growth Factors
- TGFB Transforming Growth Factors
- Osteogenic Proteins e.g., OP-1 or osteopontin
- steroids e.g., dexamethasone
- bisphosphonates e.g., steroids, dexamethasone
- the porous polyurethane/polyurethane may be attached to other tissues (e.g., soft tissue, muscle, skin, dentin).
- FIGS. 8A-B illustrate the integration of osteochondral grafts and other implants of this invention over time.
- an osteochondral graft implant 300 formed as described above has a lubricious single network hydrogel polymer or IPN hydrogel surface 302 that transitions via a graft copolymer region 304 into the polyurethane polymer 303 .
- the polyurethane polymer is the bone implant surface.
- the polyurethane which may be porous and/or may contain salt is placed next to a bone 301 . After implantation and over time, bone tissue will grow from bone 301 into and through the bone contacting surface 303 , creating an overlap zone, 309 , as illustrated in FIG. 8B .
- FIGS. 9A-C illustrate three possible configurations of osteochondral implants to repair cartilaginous join surface according to this invention.
- implant 310 is formed as a cap having a lubricious network hydrogel or IPN hydrogel surface 311 transitioning via a graft copolymer region to a bone-contacting surface 312 formed from a polyurethane, as described above.
- implant 310 covers the outer surface of bone 313 .
- FIGS. 9B and 9C show configurations in which implant 314 is formed as a patch or plug (respectively) having a lubricious network hydrogel polymer or IPN surface 315 transitioning via a graft copolymer region to a bone-contacting surface 316 formed from a polyurethane, as described above.
- implant 314 fits within a prepared opening 317 of bone 313 .
- a preexisting polymeric article can be dip casted in a solution of polyurethane with reactive end groups (monofunctional or telechelic).
- the dipcasted article can then be frozen as described above, and then dipped again in a solution ofhydrogel monomers along with appropriate initiator and crosslinker. This can then be frozen a second time.
- the material would then be exposed to UV or other suitable stimulus to initiate polymerization and grafting of the hydrogel and the underlying derivatized PU layer. After drying and washing, the end result is a hydrogel grafted to the surface of the article through an intervening layer of polyurethane.
- two polycarbonate-urethane grafted IPN hydrogels attached to polyurethane were made. The methods used were similar, and both are described here.
- Two specimens were separately synthesized by a two-step photopolymerization process using custom-made molds.
- the interpenetrating polymer network hydrogel components were synthesized by a two-step sequential network formation technique based on UV initiated free radical polymerization.
- the precursor solutions for the first hydrogel network were made of purified PEG-dimethacrylate (MW 3400) (43% by weight) dissolved in dimethylacetamide with 2-hydroxy-2-methyl propiophenone as the UV sensitive free radical initiator.
- the solutions were cast (separately) into custom-designed Pyrex glass molds, and then the solutions within the molds were flash-frozen in liquid nitrogen baths.
- 25% solutions of polycarbonate-urethane monomethacrylate (dissolved in dimethylacetamide) were spread over the frozen surfaces of the hydrogel solutions, each was covered with a glass plate, and they were reacted under a UV light source at room temperature.
- UV 2 mW/cm2, 350 nm, 10 minutes
- the hydrogel and polyurethane precursor solutions in each case underwent free-radical induced gelation while also grafting to each other due to endgroup compatibility.
- the polyurethane-grafted hydrogels were removed from the molds and immersed in 70% v/v acrylic acid solutions; in one case in organic solvent, and in the other case in water, along with 1% v/v 2-hydroxy-2-methyl propiophenone as the photoinitiator, and 1% v/v triethylene glycol dimethacrylate as the cross-linking agent for 24 hat room temperature.
- the swollen gels were exposed to a UV source and the second networks were polymerized inside the first networks to form an IPN structure in each polymer.
- the polyurethane-grafted hydrogels were washed in dimethylacetamide, dried in a convection oven (80 degrees Celsius), and washed extensively in phosphate buffered saline with repeated solvent exchanges for 5 days to remove any unreacted components.
- One sample of one material was cut in cross section and analyzed by microscopy, as shown in FIG. 10 .
- the surfaces of the polyurethane side of the hydrogels were air-dried, and then solutions of polycarbonate urethane (thermoplastic Bionate®; see FIG. 6 ) in dimethylacetamide were spread over the surface and the solvent evaporated by heat and convection.
- An analysis of the static mechanical properties of the cured and dried polyurethane containing precursors is shown in FIG. 11 .
- FIG. 10 shows a photomicrograph of a cross-section of the polyurethane-grafted hydrogel at 60 X magnification.
- the hydrogel, on the left, is 1 . 5 mm thick, while the polyurethane on the right is 0 . 6 mm.
- FIG. 11 shows the results of testing of the static mechanical properties. Uniaxial tensile tests were conducted to determine the initial Young's modulus in tension, the strain-at-break, and stress-at-break of the materials. Dog bone specimens were tested following ASTM D638. The average true stress (in MPa)—true strain curve (in %) for the joint interface polyurethane material is presented in FIG. 11 . The tensile strength is greater than 20 MPa.
- polyether urethane was used as the starting material.
- the material was made following the process described in Example 1.
- polyurethane layered onto another polyurethane was made and bonded to bone.
- Polycarbonate-urethane with methacrylate end groups was synthesized by reacting methylene diphenyl diisocyanate with polycarbonate diol (as the soft segment and 1 , 4 butanediol as the chain extender at a solid concentration of 30% in dimethylacetamide at 35 degrees Celsius.
- the monomer 2-hydroxyethyl methacrylate was added to the reaction mixture and the solution was reacted for an additional 24 hours).
- the resulting polycarbonate-urethane dimethacrylate was cast on the surface of a premade polycarbonate urethane (Bionate®) and the solvent removed at 35 degrees Celsius under convection.
- the strength of the bonding was tested by performing a lap shear test, as described in ASTM D3163. Briefly, the lap shear test involved gripping the bone and the porous polyurethane graft and pulling them in opposite directions while collecting data. The shear stress (MPa) is plotted as a function of displacement (mm). As shown in FIG. 12 , the shear stress necessary to remove the polyurethane from the bone was approximately 670 kPa. Testing of nine samples gave a mean( ⁇ S.D.) shear strength of 520 ⁇ 120 kPa.
Abstract
A composition having a hydrogel bearing side of a biostable polymer network, wherein the biostable polymer network comprises a first gradient of the biostable polymer, which biostable polymer network decreases in concentration from the hydrogel bearing side to a bone interface surface; and a second gradient of a biostable polyurethane network, which polyurethane network increases in concentration from the hydrogel bearing side to the bone interface surface, the bone interface surface useful for an orthopedic implant.
Description
- This application is a continuation of U.S. application Ser. No. 13/905,028, filed May 29, 2013, which application is a continuation of U.S. application Ser. No. 12/536,233, filed Aug. 5, 2009, entitled “Polyurethane-Grafted Hydrogels,” now issued as U.S. Patent No. 8,497,023, issued on. Jul. 30, 2013, which claims priority under 35 U.S.C §119 to U.S. Provisional Patent Application No. 61/086,442, filed Aug. 5, 2008, and entitled “Polyurethane-Grafted Hydrogels,” both of which are incorporated by reference in its entirety.
- All publications and patent applications mentioned in this specification are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference.
- The present invention relates generally to polymers, and more specifically to methods by which hydrogel and polyurethane polymers are grafted together to form two-layered structures, and by which they are attached to bone, in ways that are useful for medical and commercial devices. The invention also includes materials and articles formed by this method.
- Some polymer networks take up water and swell. These swollen hydrogels have been created from a variety of starting materials and have been used for a variety of applications. The utility of prior hydrogels for their proposed applications is limited by the properties of these compositions, however. In addition, the starting materials and processes of making and using such prior compositions limit not only the resulting properties of the polymers but also the commercial viability of the manufacturing processes and articles made in such processes. Also, the mechanical properties of the prior polymers are often limited by the mechanical properties of the component polymers used, which in the case of most intrinsically hydrophilic, water-swellable polymers, are usually quite low.
- Hydrogels have been combined with polyurethanes to form articles with certain useful properties. Hydrogel materials have been reinforced with polyurethanes and other materials to provide a more robust backing material. Also, a hydrogel coating or overlayer can be added to a hydrophobic polymer article to improve the article's biocompatibility. Prior hydrogel/polyurethane combinations have not provided the best combination of strength and swellability, however. In addition, prior methods of making hydrogel/polyurethane combinations have used expensive and/or toxic processes.
- For example, Hoffman et al. U.S. Pat. No. 3,826,678 describes a process for coating an inert polymeric substrate with a reactable hydrogel polymer and then attaching a biologically active molecule in order to make a biocompatible material with a biofunctional surface. Hoffman used “radiation grafting” to attach the hydrogel to the polyurethane and used the reactable hydrogel to attach the biologically active molecules. Hoffman's “radiation grafting” refers to application of expensive high energy to a polymer, a treatment that causes both non-specific formation of bonds and non-specific breaking of bonds. The bonds made are non-specific bonds between the two polymers anywhere along the backbone of the chains, as well as non-specific bonds (“crosslinking”) within each polymer. Conditions for using “radiation grafting” were chosen by Hoffman such that more favorable than unfavorable reactions occur.
- Hoffman used “radiation grafting” on a preformed material, such as a polyurethane, that had been contacted with a preformed hydrogel or with hydrogel monomers, and then subjected the materials to the high energy radiation (e.g., gamma irradiation or X-rays). The result was crosslinked hydrogel pieces non-specifically grafted to crosslinked polyurethane pieces. Next, the biologically active materials were attached using a specific link that bonded the biomaterial to the hydrogel. In this way, the biological materials were never subject to the fragmentation effects of the radiation treatment, and a bioactive material was made.
- Yang et al. (J. Biomed Mater Res 45:133-139, 1999) describe a process for forming a graft material having both polyurethane and hydrogel. Yang formed a mixture of polyurethane, acrylic acid, and photoinitiator, and treated it with UV light in the absence of a degassing step to create an homogeneous and unlayered acrylic acid/polyurethane polymer grafted throughout its composition.
- Park and Nho (Radiation Physics and Chemistry; 67 (2003): 361-365) describe making a wound dressing formed from polyurethane and hydrogel layers. First, polyurethane was dissolved in solvent and dried to form a polyurethane layer. Then a mixture of polyvinyl alcohol/poly-N-vinylpyrrolidone, chitosan and glycerin in water was poured onto the already formed polyurethane layer. The material was optionally treated with freeze-thaw cycles. Conditions were chosen to favor cross-linking reactions in the hydrogel over material degradation during irradiation treatment, and the material was subject to gamma irradiation to form a hydrogel. The result was a hydrogel adjacent a polyurethane; Park et al. do not describe the nature of any interaction between the polyurethane layer and the hydrogel layer.
- Wang et al. (U.S. Patent Publication 2002/00524480) describe a process for forming a material having a modified surface that can be used to tether other compounds at the surface while maintaining the bulk properties of the material. Wang started with a formed hydrophobic polymer, such as an acylic or polyurethane, and introduced a functional monomer such as acylate or vinyl monomer, and an initiator just at the polymer surface, such as by limited swelling of the polymer in a solvent. The functional monomer was treated, such as with UV irradiation, to form a second polymer. A surface modification agent, such as heparin, may be attached to the second polymer. The result was an Interpenetrating Polymer Network (IPN) at the surface between the polymerized formed polymer, with only indirect interactions between the first and second polymers, and possibly modified with a modification agent covalently attached to the second polymer.
- Gao et al. (Chinese Journal of Polymer Science Vol. 19, No. 5, (2001), 493-498) describe improvements to materials for use in improving long-term implants that become integrated into the body, such as devices put into blood vessels and in artificial hearts. Gao describes two methods to create on a segmented polyurethane a hydrophilic surface containing functional groups that will adhere cells and support growth. In both methods, the segmented polyurethane was activated by a high concentration of toxic hydrogen peroxide (30%) and UV light to generate reactive groups.
- In the “Solution Grafting Method,” of Gao, the activated segmented polyurethane was immersed in a solution of hydrophilic monomers, such as 2-(dimethylamino)ethyl methacrylate, 2-hydroxyethyl acrylate or acrylamide, and ammonium iron (II) sulfate hexahydrate, and the monomers grafted onto the segmented polyurethane by treatment with UV light. The iron compound prevents any unwanted polymerization of the monomers in solution.
- In the “Pre-Absorbing Grafting Method” of Gao, the activated segmented polyurethane membrane was immersed in a solution of hydrophilic monomers, removed, placed under nitrogen, and the hydrophilic monomers grafted onto the reactive groups of the segmented polyurethane by treatment with UV light. The membrane was rinsed with hot water for 48 hours to remove homopolymers. The result was a very thin layer of hydrophilic polymer coating on the surface of the polyurethane. SEM images of materials made using the “Solution Grafting Method” versus those made using “Pre-Absorbing Grafting Method” show significant differences in appearance in materials made using the different methods.
- The present invention improves upon prior articles made from a combination of a hydrogel and a polyurethane and methods of making such articles. The mechanical properties desired for certain medical applications is often outside the range of possibility of many hydrophilic starting materials. Hence, one aspect of this invention takes advantage of the high mechanical strength of hydrophobic starting materials and combines those materials with hydrogels as a useful way to achieve the goal of high mechanical strength in addition to other desirable properties provided by the hydrogels without the cost and issues associated with the use of highly specialized equipment (e.g., 60Co radiation source) or damage to and/or ambiguity about the composition of the formed material due to lack of specificity in the treatment to effect bonding (e.g., gamma irradiation).
- For purposes of this application, an “interpenetrating polymer network” or “IPN” is a material comprising two or more polymer networks which are at least partially interlaced on a molecular scale, but not covalently bonded to each other, and cannot be separated unless chemical bonds are broken.
- A “polymer” is a substance comprising macromolecules (comprising repeated units of monomers), including homopolymers and copolymers.
- A “copolymer” is a polymer derived from two or more species of monomer.
- A “homopolymer” is a polymer derived from a single monomeric species.
- A “graft polymer” is a polymer of that has side chains (“graft macromolecules”) containing different atoms from those in the main chain. This definition includes side chains that are polymers.
- A “graft copolymer” is a graft polymer in which adjacent blocks in the main (or in the side) chains comprise different species of monomer.
- One aspect of the invention provides an article having a hydrogel layer chemically grafted to an end-functionalized polyurethane layer. In some embodiments, the hydrogel and polyurethane are interfacially grafted. In some embodiments, the polyurethane layer may be selected from a group consisting of polycarbonate urethane, polycarbonate urethane urea, polyester urethane, polyether urethane, polyurethane urea, or a silicone derivative of these.
- The polyurethane may have hard segments, soft segments, chain extenders, and end groups. In some embodiments the hard segments are selected from the
group - In some embodiments the soft segments of the polyurethane may be selected from the group hydroxy terminated butadiene, hydroxyl terminated polyisobutylene, hydroxybutyl terminated polydimethylsiloxane (PDMS), poly (1,6
hexyl 1,2-ethyl carbonate), hydrogenated polybutadiene, polycaprolactone, polyethylene adipate, polyethylene oxide (PEO), polyhexamethylene carbonate glycol, polypropylene oxide (PPO), polytetramethylene adipate, and poly(tetramethylene oxide) (PTMO). - In some embodiments, the chain extenders of the polyurethane may be selected from the
group - In some embodiments, the polyurethane endgroups may be selected from the group acylamide, acrylate, allyl ether, methacrylate, or vinyl.
- In some embodiments the hydrogel layer may be end-linked macromeric subunits, e.g. PEG or a biomolecule, or polymerized monomeric subunits. In some embodiments, the biomolecule may be, e.g., collagen, one or more growth factors, steroids, bisphosphonates, or combinations or derivatives thereof. In some embodiments the biomolecules may be selected from the group any Bone Morphogenetic Protein, any Fibroblast Growth Factor, any Transforming Growth Factor, or any Osteogenic Protein.
- In some embodiments the hydrogel layer may be a homopolymer. In some embodiments the hydrogel may be polymerized monomeric subunits. In some embodiments, the hydrogel layer may be a copolymer. The copolymer may have a polymerized subunit, such as a subunit selected from the group consisting of acrylamide, hydroxyethyl acrylamide, N-isopropyl acrylamide, 2-hydroxyethyl methacrylate, and 2-hydroxyethyl acrylate. In some embodiments, the hydrogel network may contain at least 50%, at least 75%, or at least 90% by dry weight of telechelic macromonomer.
- In some embodiments the hydrogel layer may be an IPN with a first and second network. In some embodiments the first IPN network may be end-linked macromeric subunits. In some embodiments, the polymerized macromeric subunits may be selected from the group consisting of PEG, poly(N-vinyl pyrrolidone), polydimethylsiloxane, poly (vinyl alcohol), polysaccharide, and a biomolecule. In some embodiments the polymerized macromeric subunits may have end group or side group functionalities selected from the group consisting of acrylamide, acrylate, allyl, methacrylamide, methacrylate, N-vinyl sulfone, and vinyl.
- In some embodiments the second IPN network may be polymerized subunits (monomers). In some embodiments, the subunits may be hydrophilic. The hydrophilic subunit may be ionizable. The ionizable subunit may be anionic. The anionic subunits may include carboxylic acid and/or sulfonic acid groups. In some embodiments, the second network may be polyacrylic acid. In some embodiments, the ionizable subunit may be cationic. In some embodiments, the hydrophilic subunit may be non-ionic. The non-ionic subunit may be selected from the group consisting of acrylamide, methacrylamide, N-hydroxyethyl acrylamide, N-isopropylacrylamide, methyl methacrylate, N-vinyl pyrrolidone, 2-hydroxyethyl methacrylate, 2-hydroxyethyl acrylate, and/or derivatives of these.
- In some embodiments both networks of the IPN may be grafted to the polyurethane.
- In some embodiments, a second polyurethane may be attached to the first polyurethane. In some embodiments, the second polyurethane may have functionalized end groups. In some embodiments, the second polyurethane may include salt such as salt with crystals of size that varies from 100 μm to 1000 μm. In some embodiments, the second polyurethane may be porous, with the pore size varying, e.g.; from 10 μm to 1000 μm . In some embodiments, the second polyurethane may contain foaming agents to create open cell porosity, with the pore size varying, e.g.; from 10 μm to 1000 μm.
- In some embodiments the second polyurethane may include a biomolecule. In some embodiments, the biomolecule may be selected from the group consisting of collagen, bone morphogenetic protein, bisphosphonate, and an osteogenic protein. In some embodiments, the second polyurethane may include a bone component, i.e., a material normally found in natural bone. The bone component may be one or more of carbonated apatite, hydroxyapatite, alpha tricalcium phosphate, beta tricalcium phosphate, and other calcium phosphates.
- In some embodiments, the second polyurethane may include entrapped fillers.
- In some embodiments, the second polyurethane may include an antioxidant. The antioxidant may be selected from the group consisting of ascorbic acid, beta carotene, glutathione, Irganox®, lipoic acid, retinol, santowhite, uric acid, ubiquinol, and Vitamin E.
- Another aspect of the invention provides an article having a first polyurethane, and a second polyurethane attached to the first polyurethane, the second polyurethane having a putty-like hardness. In some embodiments, the second polyurethane has reactive end groups. In some embodiments the second polyurethane may include salt. In some embodiments, the second polyurethane may be porous.
- In some embodiments, the composition of the first and second polyurethane may include entrapped fillers.
- In some embodiments, the composition of the first and second polyurethane may include an antioxidant. The antioxidant may be selected from the group consisting of ascorbic acid, Vitamin E, Irganox, santowhite, glutathione, uric acid, lipoic acid, beta carotene, retinol, and ubiquinol.
- Another aspect of the invention provides a process for grafting a polyurethane to a hydrogel including the following steps: freezing a first solution containing either reactive hydrogel precursors or end-functionalized polyurethane precursors; applying a second solution containing either end-functionalized polyurethane precursors or reactive hydrogel precursors to the first solution; and polymerizing and crosslinking the solutions to form a laminated graft polymer having a polyurethane and a hydrogel.
- Another aspect of the invention provides a process for grafting a polyurethane to a hydrogel including the following steps: casting a layer from a solution containing end-functionalized polyurethane precursors; applying a second solution containing reactive hydrogel precursors, the second solution containing a solvent for the polyurethane layer; and polymerizing and crosslinking the solutions to form a laminated graft polymer having a polyurethane and a hydrogel.
- In some embodiments the polymerizing step uses UV light or heat.
- In some embodiments, the method may include the steps of immersing at least part of the laminated graft polymer in a third solution; the third solution having hydrogel precursors different from the precursors in the first or second solutions; swelling the graft polymer; and polymerizing the third solution to create a graft polymer having a polyurethane and an IPN, whereby the IPN has a second hydrogel network intertwined with a first hydrogel network. In some embodiments the third solution may be a partial solvent for the first hydrogel, and is able to swell the first hydrogel network.
- In some embodiments, the solution containing the hydrogel precursors may have telechelic molecules. In various embodiments, the telechelic molecules may be poly(ethylene) glycol with one or more endgroups selected from the group consisting of acrylate, methacrylate, acrylamide, vinyl, or allyl ether.
- In some embodiments, the polyurethane solution may have one or more materials selected from the group consisting of vinyl terminated polyurethane, polycarbonate urethane, polyether urethane, polycarbonate urethane urea, polyester urethane, polyurethane urea and silicone derivatives of these.
- Another aspect of the invention provides a process for making a material that can be attached to bone, including the following steps: applying a solution that contains a polyurethane precursor having reactive endgroups, and further containing solvent, photoinitiator and crosslinker to a first polyurethane that is grafted to a hydrogel; polymerizing the polyurethane precursor; and treating with heat and convection to remove the solvent to yield a second unreacted telechelic polyurethane surface coated on a polyurethane grafted hydrogel.
- In some embodiments, the second polyurethane may be polycarbonate urethane and in others polyether urethane.
- In some embodiments, the reactive endgroups may be selected from the group consisting of acrylamide, acrylate, allyl ether, methacrylate, and vinyl. In some embodiments, the solvent may be selected from the group consisting of dimethylacetamide, dimethyl sulfoxide, and tetrahydrofuran.
- In some embodiments, the applying step includes applying a salt.
- Another aspect of the invention provides a process for attaching an article to a bone, the article including a porous polyurethane having a photointiator and a crosslinker, the method including the steps of placing the porous polyurethane in apposition to the bone; and polymerizing the second polyurethane to attach the article to the bone. In some embodiments, the porous polyurethane contacts and flows into the bone. The article may also include a second polyurethane attached to the porous polyurethane and optionally a hydrogel. In some embodiments, the polymerizing step may include exposing the polyurethane to UV light, heat, or a chemical initiator.
- The polyurethane-grafted hydrogels of the present invention have numerous applications in medicine and industry. In orthopaedics, there is a great need for cartilage replacement materials that emulate the properties of natural cartilage. The invention may also be useful in other areas of orthopaedics (in any joint), such as the spine, a disc or facet replacement, or as a bursal replacement. Other applications of the polyurethane-grafted hydrogels are possible, in fields including but not limited to wound care (e.g. as a wound dressing), plastic surgery, urology (e.g. catheters), or cardiology (e.g. as a stent, catheter, or valve material).
- The polyurethane-grafted hydrogels are useful as devices in the form of plugs, patches, caps, or cups to repair defects in joint surfaces. A device is comprised of a hydrogel bearing side and a porous polyurethane bone-interface side which are chemically bonded to each other. The hydrogel side provides a lubricious, “cartilage-like” bearing surface while the polyurethane side provides structural reinforcement and facilitates bone adhesion and ingrowth. The bone interface side of the polyurethane-grafted hydrogel is adhered to bone through any of the above mentioned approaches.
- The novel features of the invention are set forth with particularity in the claims that follow. A better understanding of the features and advantages of the present invention will be obtained by reference to the following detailed description that sets forth illustrative embodiments, in which the principles of the invention are utilized, and the accompanying drawings of which:
-
FIGS. 1A-C illustrate a process by which hydrogels and polyurethanes are grafted according to one aspect of this invention. -
FIGS. 2A-B illustrate one example of a polyethylene glycol (PEG)-dimethacrylate hydrogel grafted to a methacrylate functionalized polyurethane to yield a polyurethane grafted PEG hydrogel. -
FIGS. 3A-C illustrate how an IPN is formed and grafted to a polyurethane. -
FIGS. 4A-B illustrate how a double polymer graft is formed between polyurethane and a hydrogel IPN. -
FIGS. 5A-C illustrate how a telechelic polyurethane adhesive is deposited on a polyurethane backing layer. -
FIGS. 6A-B shows examples of the polyurethane backing material and polyurethane adhesive. -
FIGS. 7A-D illustrate how the adhesive polyurethane attaches a material to bone according to one aspect of this invention -
FIGS. 8A-B illustrate how the graft copolymer attaches to bone. -
FIGS. 9A-C illustrate how an osteochondral graft implant formed from a polymer graft of this invention can be used to replace or augment cartilage within a joint. -
FIG. 10 is a shows a photomicrograph of a cross-section of the polyurethane-grafted hydrogel of a material made according to one aspect of this invention. -
FIG. 11 shows the results of testing the static material properties of a material of the current invention. -
FIG. 12 shows the results of lap shear testing to determine the strength of material made according to the current invention. -
FIGS. 13A-C illustrate the integration of osteocondral grafts and other implants of this invention into bone over time. - In one embodiment, a polyurethane is interfacially grafted to a hydrogel to create a layered strong, lubricious polymer graft material. To form the polyurethane grafted hydrogel, monomers or macromonomers of a hydrogel precursor are dissolved with photoinitiator and, optionally, a crosslinker, in an organic solvent or buffer. In some embodiments, monomers or macromonomers of a second hydrogel precursor that will form a copolymer are also dissolved.
- In some embodiments, biomolecules may be added. Monomers or macromonomers of a polyurethane precursor are also dissolved along with photoinitator, and optionally a crosslinker, in an organic solvent or buffer; the organic solvent or buffer can be the same or different composition as the one in which the hydrogel precursors are dissolved. Additional materials that will give the materials additional properties (“additives”) can be added to either or both solutions. The additives can be the same or different in the two solutions.
- Any type of organic solvent can be used to create the solutions of the monomers and macromonomers, such as dimethylacetamide, dimethyl sulfoxide, tetrahydrofuran, or chloroform.
- Any type of photoinitiator can also be used. This includes, but is not limited to, 2-hydroxy-2-methyl-propiophenone and 2-hydroxy-1-[4-(2-hydroxyethoxy) phenyl]-2-methyl-1-propanone.
- Any type of compatible cross-linkers may be used to crosslink the second network m the presence of any of the aforementioned first networks such as, for example, ethylene glycol dimethacrylate, ethylene glycol diacrylate, diethylene glycol dimethacrylate (or diacrylate), triethylene glycol dimethacrylate (or diacrylate), tetraethylene glycol dimethacrylate (or diacrylate), polyethylene glycol dimethacrylate, or polyethylene glycol diacrylate, methylene bisacrylamide, N,N′-(1,2-dihydroxyethylene)bisacrylamide, derivatives, or combinations thereof.
- Any monomer or macromonomer may be used to form the polyurethane layer. In some embodiments, the polyurethane has reactive ends. Either one or both ends of the polyurethane may be functionalized. Examples of materials that can be used are polymers having surface active endgroups. See, e.g., Ward et al, U.S. Pat. No. 5,589,563.
- In some embodiments, biomolecules (e.g., collagen, growth factors (any Bone Morphogenetic Proteins (BMPs)), Fibroblast Growth Factors (FGFs), Transforming Growth Factors (e.g., TGFB), Osteogenic Proteins (e.g., OP-1 or osteopontin), steroids (e.g., dexamethasone), and bisphosphonates may be incorporated either as an additive or by covalent linkages, combinations, and/or derivatives thereof. Bone components may also be incorporated into the device, such as hydroxyapatite, carbonated apatite, alpha tricalcium phosphate, beta tricalcium phosphate, combinations, and/or derivatives thereof. The pore size useful for this application ranges between about 10 micrometers to 1000 micrometers.
- In one embodiment, the hydrogel precursor solution containing initiator is cast over a mold and flash-frozen in, for example, a liquid nitrogen bath. The polyurethane precursor solution containing initiator is then cast over the surface of the solidified hydrogel precursor solution. The polyurethane precursor solution can be, for example, at room temperature or below. Freezing the first set of precursors before adding the second set prevents major mixing of the two sets of precursors. Polymerization and cross linking is then initiated by UV or heat.
- In another embodiment, the polyurethane precursor solution containing initiator is cast over a mold and flash-frozen in, for example, a liquid nitrogen bath. The hydrogel precursor solution containing initiator is then cast over the surface of the solidified polyurethane precursor solution. The hydrogel precursor solution can be, for example, at room temperature or below. Polymerization and cross linking is then initiated by UV or heat.
- In another embodiment, the polyurethane precursor solution, (e.g., in dimethylacetamide or tetrahydrofuran), is cast over a mold and dried (e.g., at room temperature), to form a layer. The hydrogel precursor solution, containing at least in part a solvent for the polyurethane layer (e.g., dimethylacetamide or tetrahydrofuran), is applied on the surface of the polyurethane layer. Polymerization and cross linking is initiated by UV or heat.
-
FIGS. 1A-C shows a graft polymer having a polyurethane polymer grafted to a hydrogel polymer, and the method of making, according to the current invention. -
FIG. 1A shows two layers of polymer precursors before polymerization. One precursor layer is frozen (e.g., using a liquid nitrogen bath) or otherwise solidified (e.g., by drying) and then a second precursor layer is added to the solidified layer. The figure shows one layer oftelechelic hydrogel precursors 2 withfunctional endgroups 4 and 6. The telechelic ends can be the same or different structures. The figure shows a second layer oftelechelic polyurethane precursors 8 withhard segments 10 andsoft segments 12. The functional groups, 14 and 16, on the ends of the polyurethane precursor can be the same or different structures. The “bottom” (solidified) layer comprises either set of precursors, and the “top” layer comprises the other set. In one embodiment thetelechelic polyurethane precursors 8 may be frozen. In an alternate embodiment, thehydrogel precursors 2 may be frozen. The layered solutions are covered with a glass plate and polymerized through free radical polymerization, using, for example, exposure toUV light 26. Exposure to UV light is thought to have two effects: (1) it initiates polymerization and crosslinking of the two precursor solutions, and (2) it melts at least some of the frozen hydrogel or telechelic polyurethane precursor layer, providing chain mobility at the interface between the two layers, and allowing grafting of the hydrogel to the polyurethane at the interface between the two layers. The process of polymerization may generate additional heat that melts the bulk of the frozen layer, allowing the layer to polymerize and crosslink. - Polymerization leads to the formation of a polyurethane grafted
hydrogel material 24, as shown inFIG. 1B . Thehydrogel polymer 18 is covalently bound by agraft 22 to thepolyurethane polymer 20. The hard segments of thepolyurethane polymer 20 assemble to form hard phases 26, as shown in thegraft polymer 29 inFIG. 1C . The soft segments assemble insoft phases 28. The use of an end-functionalized polyurethane precursor enables the hydrogel layer to graft to the polyurethane layer using relatively inexpensive UV polymerization while minimizing the amount of initiator (such as hydrogen peroxide) used to facilitate grafting. - Any monomer or macromonomer or biomacromolecule may be used to form the hydrogel polymer network. For convenience, the hydrogel polymer network will be referred to as the “first” network and the polyurethane polymer network as the “second” network; but it should be understood that either solution can be solidified (e.g., frozen or dried) first.
- In one embodiment, preformed polyethylene glycol (PEG) macromonomers can be used as the basis of the hydrogel polymer network. PEG is biocompatible, soluble in aqueous solution, and can be synthesized to give a wide range of molecular weights and chemical structures. The hydroxyl end-groups of the bifunctional glycol can be modified into crosslinkable/polymerizeable end-groups to form telechelic PEG molecules with vinyl endgroups such as acrylate, methacrylate, acrylamide, methyacrylamide, vinyl, or allyl ether.
-
FIGS. 2A-B show a particular example of a graft polymer having a polyurethane polymer grafted to a hydrogel polymer.FIG. 2A shows a poly(ethylene glycol) 100 having reactive dimethylacrylate endgroups 104 being polymerized and crosslinked in the presence of apolyurethane 102 havingreactive methacrylate endgroups 106. The result is a polyurethane-graftedPEG hydrogel 111 having anetwork hydrogel polymer 110 attached via acovalent linkage 114 to afunctionalized polyurethane 112. The solvent used can be water or an organic solvent, (e.g., dimethylacetamide or tetrahydrofuran). - In addition to the poly(ethylene glycol), other macromonomers such as polycarbonate, poly(N-vinyl pyrrolidone), polydimethylsiloxane, poly(vinyl alcohol), polysacchrarides (e.g., dextran), biomacromolecules (e.g., collagen) and derivatives or combinations thereof can also be chemically modified with endgroup or side-group functionalities such as acrylates, methacrylates, allyl ethers, vinyls, acrylamides, and methacrylamides and used to form the hydrogel polymer network.
- The first network can also be copolymerize with any number of other polymers including but not limited to those based on acrylamide, hydroxyethyl acrylamide, N-isopropylacrylamide, 2-hydroxyethyl methacrylate, 2-hydroxyethyl acrylate or derivatives thereof. The polymerized subunit may be a derivative of an acrylate, methacrylate, vinyl, allyl ether, or acrylamide monomer.
- Preferably, the dry weight of the first polymer network is at least 50%, more preferably at least 75% by weight, and most preferably at least 95% telechelic macromonomer.
- The polyurethane polymer of the second network can be a commercially available material or it can be a new material, including but not limited to a polycarbonate urethane, polycarbonate urethane urea, polyether urethane, segmented polyurethane urea, silicone polycarbonate urethane, or silicone polyether urethane. The molecular weight of the second polymer layer is high enough to provide structural stability to the material. The polyurethane precursor can be vinyl-terminated (on one or both ends) polyurethane, polycarbonate urethane, polycarbonate urethane ureas, polyester urethane, polyether urethane, polyurethane urea, as well as silicone derivatives of these or combinations thereof.
- Any type of chemistries and stoichiometries can be used to create the polyurethane polymer. Isocyanates that are used to generate the hard segment include 1,5 naphthalene diisocyanate (NDI), isophorone isocyanate (IPDI), 3,3-bitoluene diisocyanate (TODI), methylene bis(p-cyclohexyl isocyanate) (H12MDI), cyclohexyl diiscocyanate (CHDI), 2,6 tolylene diisocyanate or 2,4 toluene diisocyanate (TDI), hexamethyl diisocyanate, or methylene bis(p-phenyl isocyanate).
- Chemicals that may be used to generated the soft segment include hydroxy terminated butadiene, hydroxyl terminate polyisobutylene, hydroxybutyl terminated polydimethylsiloxane (PDMS), poly (1,6
hexyl 1,2-ethyl carbonate, and hydrogenated polybutadiene, polycaprolactone, polyethylene adipate, polyethylene oxide (PEO), polyhexamethylene carbonate glycol, polypropylene oxide (PPO), polytetramethylene adipate, and poly(tetramethylene oxide) (PTMO). - Chemicals used as chain extenders include 1,4 butanediol, ethylene diamine, 4,4′methylene bis(2-chloroaniline) (MOCA), ethylene glycol, and hexane diol.
- The groups that are used to functionalize the polyurethane macromonomers can be chosen from the same group listed above to functionalize the hydrogel macromoners (e.g., acrylamides, acrylates, allyl ethers, methacrylamides, methacrylates, and vinyls). The functional groups can be on one or both ends, and they can be the same groups or different groups.
- Free radical polymerization of the above process may be initiated by other means, such as thermal-initiation and other chemistries not involving the use of ultraviolet light.
- Any number of additives can be incorporated into the materials on either the hydrogel side or the polyurethane side. These additives can be included as entrapped fillers or as covalently attached molecules or particles. For instance, anti-oxidants can be covalently linked into the hydrogel by methacryloxy-functionalization of the anti-oxidant. In one example, a methacrylate group can be regioselectively attached to the primary hydroxyl group of L-ascorbic acid (Vitamin C) by reaction of 2,2,2 trifluoromethyl methacrylate with an immobilized lipase enzyme from Candida Antarctica at 60 degrees Celsius in dioxane in the presence of a polymerization inhibitor (e.g. hydroquinone or di-tert-butyl methyl phenol). Other anti-oxidants can be added, including but not limited to beta carotene, glutathione, Irganox®, lipoic acid, retinol, santowhite, ubiquinol, uric acid, or Vitamin E).
- In another embodiment, a second hydrogel network can be added to the first hydrogel network by swelling the hydrogel grafted polyurethane or the first hydrogel network portion of the hydrogel grafted polyurethane in a second solution containing hydrogel precursors with initiator. The second solution may act as a partial solvent for the hydrogel network to swell it without dissolving. The precursors of the second hydrogel network are polymerized inside the first hydrogel network. The result is an interpenetrating polymer network (1PN) grafted to a polyurethane.
-
FIGS. 3A-C show an embodiment of a graft polymer having a polyurethane grafted interpenetrating polymer network hydrogel. -
FIG. 3A shows a polyurethane graftedhydrogel 24 having apolyurethane polymer 20 grafted to asingle hydrogel network 18 viagraft linkage 22. Thepolyurethane polymer 20 has hard phases 26 andsoft phases 28. The polymer graft is swollen in a solution of asecond hydrogel precursor 30 as shown inFIG. 3B , along with optional crosslinker and photoinitiator (not shown). Thesecond hydrogel precursor 30 is polymerized, as byUV light 36, to form asecond hydrogel network 34 interpenetrated within afirst hydrogel network 18 as shown inFIG. 3C . The final result is a polyurethane-grafted interpenetratingpolymer network hydrogel 32. - In another embodiment, a second hydrogel network can be added to the first hydrogel network. The hydrogel grafted polyurethane is swollen in a second solution containing hydrogel precursors with optional crosslinker and photoinitiator. The second solution may act as a partial solvent for the hydrogel network. Then the precursors of the second hydrogel network are polymerized and crosslinked inside the first hydrogel network to yield a polymer graft, with both hydrogels of the interpenetrating polymer network grafted to polyurethane. The polyurethane second network that is grafted to the first hydrogel network has available reactive groups, such as excess isocyanate.
-
FIGS. 4A-B show an example of a double graft polymer having a polyurethane polymer grafted to two networks of a hydrogel IPN.FIG. 4A shows afirst hydrogel network 124 crosslinked 136 to apolyurethane 130 which has excessfunctional groups 132 such as isocyanate. Thefirst hydrogel network 124 is entangled with asecond hydrogel network 126 forming ahydrogel IPN 120. Thesecond hydrogel network 126 hasfunctional groups 128 such as carboxylate. Thefunctional group 128 of the second hydrogel network interacts with thereactive group 132 of the polyurethane to form abond 134, and yield adouble polymer graft 122, as shown inFIG. 4 . - In one embodiment, the hydrophilic precursor in the second hydrogel network is ionizable and anionic (capable of being negatively charged) to yield an ionizable second hydrogel network.
- The ionizable second hydrogel polymer network can be poly(acrylic acid) (PAA) hydrogel formed from an aqueous solution of acrylic acid monomers. Other ionizable monomers include ones that contain negatively charged carboxylic acid or sulfonic acid groups, such as 2-acrylamido-2-methylpropanesulfonic acid, methacrylic acid, hyaluronic acid, heparin sulfate, chondroitin sulfate, and derivatives, or combinations thereof.
- The second hydrogel network monomer may also be positively charged or cationic.
- The hydrophilic precursor for the second hydrogel polymer network may also be non-ionic, such as acrylamide, methacrylamide, N-hydroxyethyl acrylamide, N-isopropylacrylamide, methylmethacrylate, N-vinyl pyrrolidone, 2-hydroxyethyl methacrylate, 2-hydroxyethyl acrylate or derivatives thereof. In other embodiments, these can be copolymerized with ionizable monomers, or with less hydrophilic species such as methylmethacrylate or other more hydrophobic monomers or macromonomers. Crosslinked linear polymer chains (i.e., macromolecules) based on these monomers may also be used in the second network, as well as biomacromolecules such as proteins and polypeptides (e.g., collagen, hyaluronic acid, or chitosan).
- Other aspects of this invention are methods for bonding polyurethane to bone. In one embodiment, a telechelic polyurethane with photoreactive endgroups in an organic solvent with photoinitiator and crosslinker is coated onto a polyurethane. The solvent is removed under heat (e.g., 35 degrees Celsius) and convection for about 24-72 hours to yield a putty-like layer of end-linkable polyurethane layered on top of a preexisting polyurethane. Coating an existing polyurethane layer in this fashion effectively bonds the two materials together through packing of the hard segments of the two polyurethanes, effectively creating a single body. The putty is then pressed into a prepared surface of bone and the polyurethane exposed to a stimulus, such as
- UV light, to induce polymerization and crosslinking. This leads to mechanical interlocking of the polyurethane within the pores of the bone.
- In some embodiments, the polyurethane is polycarbonate urethane or polyether urethane.
- In some embodiments, the photoreactive endgroups on the polyurethane may be acrylamide, acrylate, allyl ether, methacrylate, or vinyl.
- In some embodiments, the organic solvent may be dimethylacetamide, dimethyl sulfoxide, or tetrahydrofuran or combinations of these.
- In some embodiments, the polyurethane may comprise a copolymer comprising linking monomers. The linking monomers may include acrylamide, dimethyl acrylamide, HEMA, triethylene glycol dimethacrylate, methyl methacrylate, and hydroxy ethyl acrylate (HEA). The linking monomers may improve the strength of the putty.
- In another embodiment, salts are incorporated into the bone contacting layer. Any type of salt may be used. After incorporation of the putty into the bone and over time, the salts may be dissolved (e.g., NaCl) by body fluids or resorbed (e.g., tricalcium phosphate or carbonated apatite) by the body.
- In some embodiments, the polyurethane may be attached to a hydrogel, such as described above.
- In other embodiments, thermal, chemical-initiated or other methods of causing polymerization are used may be used to polymerize and crosslink the putty that has been pressed into a prepared surface of bone.
-
FIGS. 5A-C show how a telechelic adhesive polyurethane is deposited onto a first polyurethane. The adhesive polyurethane can be osteoconductive and/or porous. -
FIG. 5A shows an adhesivetelechelic polyurethane precursor 38 havinghard segments 40, asoft segment 42, and functional endgroups 44 and 46. Theendgroups FIG. 5B and C show the simplest case in which thepolyurethane precursor 38 is a single monomer with no repeats (n=1), but in practice the polyurethane precursor may have any number of repeating units (n>1).FIG. 5A also shows a material 50 with apolyurethane backing layer 52, and optionally ahydrogel layer 54 bonded to the polyurethane backing layer. The material 50 can be in the shape of a device such as for orthopedic use. In the presence of solvent 66, thepolyurethane precursors 38 can be coated onto the surface of the material 50 to form anunreacted putty layer 70 on thepolyurethane 52 with the putty layer and the backing layer held together by crystallization of the hard segments to create asingle body 68, as shown inFIG. 5B . The putty layer is cured by treatment withUV light 74 and removal of solvent 76, to form a reacted adhesive 80 as shown inFIG. 5C . Optionally,salt 78 can be included in the reacted adhesive. The salt causes the material to be osteoconductive, or, after its removal, to form pores which allows for ingrowth of new bone. - In other embodiments, a foaming agent may be added to the polyurethane precursor solution or the second polyurethane to create open cell porosity. The porosity may vary in size, e.g., from about 10 μm to about 1000 μm.
- In other embodiments, the solvent is removed prior to the UV curing step. In another embodiment, the solvent is removed after the UV curing step.
- In other embodiments, thermal, chemical-initiated or other methods of effecting polymerization are used to coat the second polyurethane onto the first polyurethane-backed hydrogel following the process above.
- In some embodiments, the reactive group of the second, telechelic polyurethane can be an acrylamide, acrylate, allyl ether, methacrylate, or vinyl group.
-
FIG. 6A-B show examples of materials that can be used in the present invention.FIG. 6A shows the structure of Bionate® polycarbonate-urethane that can be used in a polyurethane grafted hydrogel such as those as described inFIGS. 1 and 3 , and as the backing material inFIG. 5 .FIG. 6B shows Bionate® polycarbonate-urethane with acrylate functionalized end-groups that can be used as the adhesive layer such as described inFIGS. 5A-C . The lowercase “m” and “n” indicate that the polyurethane can have any number of soft and hard segments. -
FIGS. 7A-C show a schematic of how a device can be attached to a bone using the polyurethane of the present invention.FIG. 7A shows a device, 200, such as an orthopedic device, with a layer of polyurethane adhesive orputty 202 which containssalt 204. The putty attached to the device is apposed to a prepared surface ofbone 206, and theputty 202 is made to interdigitate around thebone 206, as shown inFIG. 7B . As shown inFIG. 7C , with the application ofUV light 214 or other stimulus, the putty cures around thebone 208. With washing, or over time, the salt is removed, and pores 210 are left behind it its place. The pores provide a space fornew bone growth 212 into the curedputty 208 as shown inFIG. 7D , thereby anchoring the device in place. - In addition, other therapeutic agents may also be incorporated into the putty, including but not limited to antibiotics and antimicrobials.
- In another embodiment, a porous polyurethane is incorporated into the polyurethane backing layer of the present invention. This porous polyurethane can be incorporated by casting a salt-saturated (about 25%-90% by weight) solution of polyurethane in an organic solvent (about 10%-75% by weight) such as dimethylacetamide or dimethyl sulfoxide, evaporating the solvent under heat (e.g. 80° Celsius) and convection, and then washing the salt away in water. The salt can be any type of salt, including but not limited to sodium chloride or calcium phosphate or derivatives and/or combinations of these. The resulting porous backing layer can serve as a surface for attachment to bone using commercially available adhesives or cements (e.g., bone cements or dental cements) while also serving as a porous scaffold for bone ingrowth.
- In some embodiments, biomolecules (e.g., collagen, growth factors (such as Bone Morphogenetic Proteins (BMPs)), Fibroblast Growth Factors (FGFs), Transforming Growth Factors (e.g., TGFB), Osteogenic Proteins (e.g., OP-1 or osteopontin), steroids (e.g., dexamethasone), and bisphosphonates) may be incorporated into the device either as an additive or by covalent linkages, combinations, and/or derivatives thereof. Bone components may also be incorporated into the device, such as hydroxyapatite, carbonated apatite, alpha tricalcium phosphate, beta tricalcium phosphate, combinations, and/or derivatives thereof. The pore size useful for this application ranges between about 10 micrometers to 1000 micrometers.
- In some embodiments, the porous polyurethane/polyurethane may be attached to other tissues (e.g., soft tissue, muscle, skin, dentin).
-
FIGS. 8A-B illustrate the integration of osteochondral grafts and other implants of this invention over time. InFIG. 8A , anosteochondral graft implant 300 formed as described above has a lubricious single network hydrogel polymer orIPN hydrogel surface 302 that transitions via agraft copolymer region 304 into thepolyurethane polymer 303. The polyurethane polymer is the bone implant surface. The polyurethane, which may be porous and/or may contain salt is placed next to abone 301. After implantation and over time, bone tissue will grow frombone 301 into and through thebone contacting surface 303, creating an overlap zone, 309, as illustrated inFIG. 8B . -
FIGS. 9A-C illustrate three possible configurations of osteochondral implants to repair cartilaginous join surface according to this invention. InFIG. 9A ,implant 310 is formed as a cap having a lubricious network hydrogel orIPN hydrogel surface 311 transitioning via a graft copolymer region to a bone-contactingsurface 312 formed from a polyurethane, as described above. When implanted,implant 310 covers the outer surface ofbone 313. -
FIGS. 9B and 9C show configurations in which implant 314 is formed as a patch or plug (respectively) having a lubricious network hydrogel polymer orIPN surface 315 transitioning via a graft copolymer region to a bone-contactingsurface 316 formed from a polyurethane, as described above. When implanted,implant 314 fits within aprepared opening 317 ofbone 313. - In another variation, a preexisting polymeric article (polyurethane or otherwise) can be dip casted in a solution of polyurethane with reactive end groups (monofunctional or telechelic). The dipcasted article can then be frozen as described above, and then dipped again in a solution ofhydrogel monomers along with appropriate initiator and crosslinker. This can then be frozen a second time. The material would then be exposed to UV or other suitable stimulus to initiate polymerization and grafting of the hydrogel and the underlying derivatized PU layer. After drying and washing, the end result is a hydrogel grafted to the surface of the article through an intervening layer of polyurethane.
- In one example, two polycarbonate-urethane grafted IPN hydrogels attached to polyurethane were made. The methods used were similar, and both are described here. Two specimens were separately synthesized by a two-step photopolymerization process using custom-made molds. The interpenetrating polymer network hydrogel components were synthesized by a two-step sequential network formation technique based on UV initiated free radical polymerization. The precursor solutions for the first hydrogel network were made of purified PEG-dimethacrylate (MW 3400) (43% by weight) dissolved in dimethylacetamide with 2-hydroxy-2-methyl propiophenone as the UV sensitive free radical initiator. The solutions were cast (separately) into custom-designed Pyrex glass molds, and then the solutions within the molds were flash-frozen in liquid nitrogen baths. 25% solutions of polycarbonate-urethane monomethacrylate (dissolved in dimethylacetamide) were spread over the frozen surfaces of the hydrogel solutions, each was covered with a glass plate, and they were reacted under a UV light source at room temperature. Upon exposure to UV (2 mW/cm2, 350 nm, 10 minutes), the hydrogel and polyurethane precursor solutions in each case underwent free-radical induced gelation while also grafting to each other due to endgroup compatibility. To incorporate the second hydrogel networks into the first, the polyurethane-grafted hydrogels were removed from the molds and immersed in 70% v/v acrylic acid solutions; in one case in organic solvent, and in the other case in water, along with 1% v/v 2-hydroxy-2-methyl propiophenone as the photoinitiator, and 1% v/v triethylene glycol dimethacrylate as the cross-linking agent for 24 hat room temperature. The swollen gels were exposed to a UV source and the second networks were polymerized inside the first networks to form an IPN structure in each polymer. Following synthesis, the polyurethane-grafted hydrogels were washed in dimethylacetamide, dried in a convection oven (80 degrees Celsius), and washed extensively in phosphate buffered saline with repeated solvent exchanges for 5 days to remove any unreacted components. One sample of one material was cut in cross section and analyzed by microscopy, as shown in
FIG. 10 . To add an additional layer of polyurethane to other samples, the surfaces of the polyurethane side of the hydrogels were air-dried, and then solutions of polycarbonate urethane (thermoplastic Bionate®; seeFIG. 6 ) in dimethylacetamide were spread over the surface and the solvent evaporated by heat and convection. An analysis of the static mechanical properties of the cured and dried polyurethane containing precursors is shown inFIG. 11 . -
FIG. 10 shows a photomicrograph of a cross-section of the polyurethane-grafted hydrogel at 60X magnification. The hydrogel, on the left, is 1.5 mm thick, while the polyurethane on the right is 0.6mm. -
FIG. 11 shows the results of testing of the static mechanical properties. Uniaxial tensile tests were conducted to determine the initial Young's modulus in tension, the strain-at-break, and stress-at-break of the materials. Dog bone specimens were tested following ASTM D638. The average true stress (in MPa)—true strain curve (in %) for the joint interface polyurethane material is presented inFIG. 11 . The tensile strength is greater than 20 MPa. - In another example, polyether urethane was used as the starting material. The material was made following the process described in Example 1.
- In another example, polyurethane layered onto another polyurethane was made and bonded to bone. Polycarbonate-urethane with methacrylate end groups was synthesized by reacting methylene diphenyl diisocyanate with polycarbonate diol (as the soft segment and 1, 4 butanediol as the chain extender at a solid concentration of 30% in dimethylacetamide at 35 degrees Celsius. The monomer 2-hydroxyethyl methacrylate was added to the reaction mixture and the solution was reacted for an additional 24 hours). The resulting polycarbonate-urethane dimethacrylate was cast on the surface of a premade polycarbonate urethane (Bionate®) and the solvent removed at 35 degrees Celsius under convection.
- After the solvent was removed, the unreacted polycarbonate-urethane dimethacrylate was pressed onto the surface of a previously prepared (cleaned and dried) bovine bone specimen, and exposed to UV light (2 mW/cm2, 350 nm, for 10 minutes). The result was polycarbonate urethane bonded to bone.
- The strength of the bonding was tested by performing a lap shear test, as described in ASTM D3163. Briefly, the lap shear test involved gripping the bone and the porous polyurethane graft and pulling them in opposite directions while collecting data. The shear stress (MPa) is plotted as a function of displacement (mm). As shown in
FIG. 12 , the shear stress necessary to remove the polyurethane from the bone was approximately 670 kPa. Testing of nine samples gave a mean(±S.D.) shear strength of 520±120 kPa. - While preferred embodiments of the present invention have been shown and described herein, it will be obvious to those skilled in the art that such embodiments are provided by way of example only. Numerous variations, changes, and substitutions will now occur to those skilled in the art without departing from the invention. It should be understood that various alternatives to the embodiments of the invention described herein may be employed in practicing the invention. It is intended that the following claims define the scope of the invention and that methods and structures within the scope of these claims and their equivalents be covered thereby.
Claims (16)
1. An orthopedic implant device, said implant device comprising:
a composition comprising two or more polymer networks having a hydrogel bearing side of a polymer network, wherein the polymer network comprises a first gradient of the polymer, which polymer network decreases in concentration from the hydrogel bearing side to a bone interface surface; and
a second gradient of a polyurethane network, which polyurethane network increases in concentration from the hydrogel bearing side to the bone interface surface, the bone interface surface of the polyurethane network comprises an osteochondral graft, wherein the orthopedic implant device is a cartilage replacement prosthesis.
2. The orthopedic implant device of claim 1 , wherein the polymer is polyacrylic acid, without polyethylene glycol.
3. The orthopedic implant device of claim 1 , wherein at least one of the networks is a covalently cross-linked network.
4. The orthopedic implant device of claim 1 , further comprising an antioxidant.
5. The orthopedic implant device of claim 1 , further comprising water.
6. The orthopedic implant device of claim 1 , wherein the polyurethane includes a pourous polyurethane, which is a bone anchoring layer.
7. The orthopedic implant device of claim 6 , wherein the porosity is made by incorporating a porogen into the polyurethane that is leached out.
8. The orthopedic implant device of claim 7 , wherein the bone interface surface is a bone-like porous structure.
9. The orthopedic implant device of claim 6 , wherein the porous polyurethane further comprises an osteoconductive agent.
10. The orthopedic implant device of claim 1 , wherein the hydrogel bearing side is a lubricious surface.
11. The orthopedic implant device of claim 1 , wherein the device has a shape selected from the group consisting of a cap, a cup, a plug, and a patch.
12. The orthopedic implant device of claim 1 , wherein the hydrogel bearing side is grafted to the polyurethane.
13. The orthopedic implant device of claim 12 , wherein the polyurethane network is grafted through vinyl end groups.
14. The orthopedic implant device of claim 12 , wherein the composition is a hybrid copolymer/interpenetrating polymer network.
15. The orthopedic implant device of claim 1 , wherein the polyurethane network comprises polycarbonate urethane, polycarbonate urethane urea, polyether urethane, polyether urethane urea, or a silicone-containing derivative of thereof.
16. The orthopedic implant device of claim 15 , wherein the polyurethane is a polyether urethane.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/243,843 US20140213661A1 (en) | 2008-08-05 | 2014-04-02 | Hydrophilic interpenetrating polymer networks derived from hydrophobic polymers |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8644208P | 2008-08-05 | 2008-08-05 | |
US12/536,233 US8497023B2 (en) | 2008-08-05 | 2009-08-05 | Polyurethane-grafted hydrogels |
US13/905,028 US8853294B2 (en) | 2008-08-05 | 2013-05-29 | Polyurethane-grafted hydrogels |
US14/243,843 US20140213661A1 (en) | 2008-08-05 | 2014-04-02 | Hydrophilic interpenetrating polymer networks derived from hydrophobic polymers |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/905,028 Continuation US8853294B2 (en) | 2008-08-05 | 2013-05-29 | Polyurethane-grafted hydrogels |
Publications (1)
Publication Number | Publication Date |
---|---|
US20140213661A1 true US20140213661A1 (en) | 2014-07-31 |
Family
ID=41651814
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/536,233 Expired - Fee Related US8497023B2 (en) | 2008-08-05 | 2009-08-05 | Polyurethane-grafted hydrogels |
US13/905,028 Expired - Fee Related US8853294B2 (en) | 2008-08-05 | 2013-05-29 | Polyurethane-grafted hydrogels |
US14/243,843 Abandoned US20140213661A1 (en) | 2008-08-05 | 2014-04-02 | Hydrophilic interpenetrating polymer networks derived from hydrophobic polymers |
US14/508,895 Abandoned US20150025161A1 (en) | 2008-08-05 | 2014-10-07 | Polyurethane-grafted hydrogels |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/536,233 Expired - Fee Related US8497023B2 (en) | 2008-08-05 | 2009-08-05 | Polyurethane-grafted hydrogels |
US13/905,028 Expired - Fee Related US8853294B2 (en) | 2008-08-05 | 2013-05-29 | Polyurethane-grafted hydrogels |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/508,895 Abandoned US20150025161A1 (en) | 2008-08-05 | 2014-10-07 | Polyurethane-grafted hydrogels |
Country Status (7)
Country | Link |
---|---|
US (4) | US8497023B2 (en) |
EP (1) | EP2323670A4 (en) |
JP (1) | JP5722773B2 (en) |
KR (1) | KR20110040969A (en) |
AU (1) | AU2009279716A1 (en) |
CA (1) | CA2731698A1 (en) |
WO (1) | WO2010017282A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2017007100A (en) * | 2015-06-16 | 2017-01-12 | 株式会社春日井化成工業所 | Production method for urethane-based molding |
US11116702B2 (en) * | 2016-12-14 | 2021-09-14 | Dentsply Sirona Inc. | Dental composition |
Families Citing this family (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090088846A1 (en) * | 2007-04-17 | 2009-04-02 | David Myung | Hydrogel arthroplasty device |
US20120209396A1 (en) | 2008-07-07 | 2012-08-16 | David Myung | Orthopedic implants having gradient polymer alloys |
US8497023B2 (en) | 2008-08-05 | 2013-07-30 | Biomimedica, Inc. | Polyurethane-grafted hydrogels |
WO2011075742A1 (en) * | 2009-12-18 | 2011-06-23 | Biomimedica, Inc. | Method, device, and system for shaving and shaping of a joint |
US9999702B2 (en) | 2010-04-09 | 2018-06-19 | Kci Licensing Inc. | Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds |
US8632512B2 (en) * | 2010-04-09 | 2014-01-21 | Kci Licensing, Inc. | Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds |
EP2609154B1 (en) * | 2010-08-27 | 2020-04-22 | Hyalex Orthopaedics, Inc. | Hydrophobic and hydrophilic interpenetrating polymer networks derived from hydrophobic polymers and methods of preparing the same |
CN102068323B (en) * | 2011-01-21 | 2014-03-26 | 南京师范大学 | Cardiac or vascular patch with anticoagulant effect |
US8597264B2 (en) | 2011-03-24 | 2013-12-03 | Kci Licensing, Inc. | Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds |
WO2013043529A1 (en) | 2011-09-19 | 2013-03-28 | Emory University | Bone morphogenetic protein pathway activation, compositions for ossification, and methods related thereto |
WO2013052105A2 (en) | 2011-10-03 | 2013-04-11 | Biomimedica, Inc. | Polymeric adhesive for anchoring compliant materials to another surface |
WO2013078284A1 (en) | 2011-11-21 | 2013-05-30 | Biomimedica, Inc. | Systems, devices, and methods for anchoring orthopaedic implants to bone |
CN102526810B (en) * | 2012-02-22 | 2014-04-09 | 四川大学 | Artificial skin alternative material and preparation method thereof |
US9574057B2 (en) * | 2012-03-28 | 2017-02-21 | Becton, Dickinson And Company | Hydrogel adhesion to molded polymers |
US20150282934A1 (en) * | 2012-10-11 | 2015-10-08 | Poly-Med, Inc. | Multilayer polymeric compositions and methods relating thereto |
ES2466065B1 (en) * | 2012-12-07 | 2015-03-31 | Universidade De Santiago De Compostela | Modification of polyurethane with polymers sensitive to biocompatible stimuli for drug loading and transfer |
WO2014110407A2 (en) * | 2013-01-11 | 2014-07-17 | Surmodics, Inc. | Conductive polymers and uses |
EP2976095B1 (en) | 2013-03-15 | 2020-12-23 | 3M Innovative Properties Company | Wound healing compositions |
CA3075578C (en) * | 2013-04-26 | 2022-07-26 | New York Society For The Ruptured And Crippled Maintaining The Hospital For Special Surgery | A multi-component non-biodegradable implant, a method of making and a method of implantation |
BR102013014155B1 (en) * | 2013-06-07 | 2021-08-31 | Universidade Federal Do Pará - Ufpa | Bionanocomposite for bone recovery, use of bionanocomposite |
US9976047B2 (en) | 2013-06-25 | 2018-05-22 | Polyone Corporation | Acrylic-urethane IPN plastisol |
KR101492051B1 (en) * | 2013-07-08 | 2015-02-16 | 아주대학교산학협력단 | hydrogel prepared by electrostatic attraction between cationic material and anionic material, and method for preparing the same |
JP6292815B2 (en) * | 2013-10-10 | 2018-03-14 | 京セラ株式会社 | Antioxidant prosthetic material |
CN103893818B (en) * | 2014-03-14 | 2015-07-01 | 华南理工大学 | Osteochondral three-dimensional stent with regular interpenetrating network structure and preparation method thereof |
JP2017524398A (en) * | 2014-06-04 | 2017-08-31 | クロクス テクノロジーズ インコーポレイテッド | Biophoto hydrogel |
WO2017004136A1 (en) | 2015-06-30 | 2017-01-05 | Tela Bio, Inc. | Corner-lock stitch patterns |
US10426587B2 (en) | 2015-07-21 | 2019-10-01 | Tela Bio, Inc. | Compliance control stitching in substrate materials |
AU2016301103B9 (en) | 2015-07-24 | 2019-08-08 | Trimph Ip Pty Ltd | Antiseptic polymer and synthesis thereof |
AU2016305968B2 (en) * | 2015-08-10 | 2021-02-25 | Hyalex Orthopaedics, Inc. | Interpenetrating polymer networks |
US11077228B2 (en) | 2015-08-10 | 2021-08-03 | Hyalex Orthopaedics, Inc. | Interpenetrating polymer networks |
US10668183B2 (en) * | 2016-03-02 | 2020-06-02 | The Board Of Trustees Of The Leland Stanford Junior University | Bone-tendon graft biomaterial, use as a medical device and method of making same |
US9820843B2 (en) | 2016-04-26 | 2017-11-21 | Tela Bio, Inc. | Hernia repair grafts having anti-adhesion barriers |
CN109923151B (en) | 2016-11-03 | 2021-08-20 | 3M创新有限公司 | Silicone copolymers, methods of manufacture, and articles |
WO2018101358A1 (en) | 2016-11-29 | 2018-06-07 | Spiber株式会社 | Protein composition, method for producing same and method for improving heat stability |
US10328888B2 (en) * | 2016-12-15 | 2019-06-25 | Ford Global Technologies, Llc | Lap-belt length detecting seatbelt assembly |
KR102629420B1 (en) * | 2017-11-16 | 2024-01-25 | 에스더블유엠 룩셈부르크 | Thermoplastic polymer film with interpenetrating polymer network |
US11590262B2 (en) | 2018-03-09 | 2023-02-28 | Tela Bio, Inc. | Surgical repair graft |
US10882945B2 (en) | 2018-03-26 | 2021-01-05 | Medtronic, Inc. | Modified polyisobutylene-based polymers, methods of making, and medical devices |
US10869950B2 (en) | 2018-07-17 | 2020-12-22 | Hyalex Orthopaedics, Inc. | Ionic polymer compositions |
CN109111583B (en) * | 2018-08-27 | 2020-08-21 | 晋江瑞碧科技有限公司 | Preparation method of polyurethane nanofiber membrane grafted poly (N-isopropylacrylamide) hydrogel |
CN109134887B (en) * | 2018-08-27 | 2020-06-05 | 晋江瑞碧科技有限公司 | Preparation method of polyurethane nanofiber membrane grafted poly (N-isopropylacrylamide-co-acrylic acid) hydrogel |
CN109513045B (en) * | 2018-11-20 | 2021-01-15 | 温州生物材料与工程研究所 | Protein-based hydrogel with double layers of different internal pore diameter structures and preparation method thereof |
US11446130B2 (en) | 2019-03-08 | 2022-09-20 | Tela Bio, Inc. | Textured medical textiles |
CN110038157B (en) * | 2019-04-26 | 2020-07-14 | 四川大学 | Jet type photocuring hydrogel dressing precursor liquid based on polyurethane and preparation method thereof |
KR102553303B1 (en) * | 2020-07-08 | 2023-07-07 | 주식회사 아이센스 | Functionalized thermoplastic polyurethane, method for preparing the same, method for preparing high performance composite in medical application and medical device comprising the same |
US11820866B2 (en) * | 2020-08-21 | 2023-11-21 | United States Of America As Represented By The Administrator Of Nasa | Copoly(urethane carbonates) with tunable properties and methods for making and using the same |
CN112225919B (en) * | 2020-09-11 | 2023-07-25 | 王平 | Geomembrane for soil remediation engineering and preparation method thereof |
TWI756908B (en) * | 2020-11-05 | 2022-03-01 | 研庚實業股份有限公司 | Water-repellent elastic film for wetsuits |
CN113061263B (en) * | 2021-04-06 | 2021-12-17 | 华东理工大学 | Preparation method of photocrosslinking dynamic reversible supramolecular polymer adhesive based on lipoic acid micromolecular compound |
US11801143B2 (en) | 2021-07-01 | 2023-10-31 | Hyalex Orthopaedics, Inc. | Multi-layered biomimetic osteochondral implants and methods of using thereof |
CN113754856A (en) * | 2021-09-18 | 2021-12-07 | 天津中杰超润医药科技有限公司 | Self-assembled micelle, dispersion-enhanced wear-resistant fatigue-resistant bionic meniscus and preparation method |
CN114230732B (en) * | 2021-12-30 | 2022-12-02 | 华中科技大学 | Method for chemically grafting hydrophobic polymer and hydrogel layer |
CN114405287B (en) * | 2022-01-24 | 2022-10-28 | 中国科学院苏州纳米技术与纳米仿生研究所 | Superstrong oil stain resistance oil-water separation membrane and preparation method and application thereof |
CN114349913A (en) * | 2022-01-26 | 2022-04-15 | 中国科学院化学研究所 | Photosensitive resin for preparing single-network high-strength high-toughness hydrogel and application of photosensitive resin in photocuring 3D printing |
WO2023196414A1 (en) * | 2022-04-05 | 2023-10-12 | Cornell University | Systems and methods for glucose-responsive insulin delivery |
CN115814158B (en) * | 2022-12-01 | 2024-02-23 | 中山大学 | Wear-resistant lubricating coating similar to articular cartilage and preparation method thereof |
CN115845135B (en) * | 2022-12-01 | 2024-02-23 | 中山大学 | Anti-fouling wear-resistant lubricating coating similar to articular cartilage and preparation method thereof |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4423099A (en) * | 1980-07-28 | 1983-12-27 | Ciba-Geigy Corporation | Membrane modified hydrogels |
US5091205A (en) * | 1989-01-17 | 1992-02-25 | Union Carbide Chemicals & Plastics Technology Corporation | Hydrophilic lubricious coatings |
US5576072A (en) * | 1995-02-01 | 1996-11-19 | Schneider (Usa), Inc. | Process for producing slippery, tenaciously adhering hydrogel coatings containing a polyurethane-urea polymer hydrogel commingled with at least one other, dissimilar polymer hydrogel |
US20050287187A1 (en) * | 2003-10-02 | 2005-12-29 | Mansmann Kevin A | Hydrogel implants for replacing hyaline cartilage, with charged surfaces and improved anchoring |
US7220491B2 (en) * | 2002-12-19 | 2007-05-22 | Kimberly-Clark Worldwide, Inc. | Lubricious coating for medical devices |
US20090088846A1 (en) * | 2007-04-17 | 2009-04-02 | David Myung | Hydrogel arthroplasty device |
US8497023B2 (en) * | 2008-08-05 | 2013-07-30 | Biomimedica, Inc. | Polyurethane-grafted hydrogels |
Family Cites Families (327)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1032540B (en) | 1957-04-15 | 1958-06-19 | Roehm & Haas Gmbh | Process for the production of acrylate-based plastics with reduced flammability |
US3053251A (en) * | 1959-03-30 | 1962-09-11 | Black Maurice | Joint prosthesis |
US4302553A (en) | 1970-10-30 | 1981-11-24 | Harry L. Frisch | Interpenetrating polymeric networks |
US3702611A (en) * | 1971-06-23 | 1972-11-14 | Meyer Fishbein | Surgical expansive reamer for hip socket |
US3833404A (en) | 1972-05-31 | 1974-09-03 | Research Corp | Vibration or sound damping coating for vibratory structures |
US3826678A (en) * | 1972-06-06 | 1974-07-30 | Atomic Energy Commission | Method for preparation of biocompatible and biofunctional materials and product thereof |
US3939049A (en) * | 1974-04-10 | 1976-02-17 | The United States Of America As Represented By The United States Energy Research And Development Administration | Process for radiation grafting hydrogels onto organic polymeric substrates |
US4192827A (en) * | 1974-06-27 | 1980-03-11 | Ciba-Geigy Corporation | Water-insoluble hydrophilic copolymers |
DE2512407A1 (en) | 1975-03-21 | 1976-09-23 | Heinz Prof Dr Med Wagner | HIP HEAD CAP FOR A HIP PROSTHESIS |
US4391797A (en) | 1977-01-05 | 1983-07-05 | The Children's Hospital Medical Center | Systems for the controlled release of macromolecules |
US4128600A (en) | 1977-01-14 | 1978-12-05 | General Mills Chemicals, Inc. | Interpenetrating dual cure resin compositions |
CH612585A5 (en) | 1977-05-23 | 1979-08-15 | Sulzer Ag | |
DE2914737C3 (en) | 1979-04-11 | 1981-12-10 | Feldmühle AG, 4000 Düsseldorf | Femoral head cap endoprosthesis |
US4320709A (en) | 1980-09-29 | 1982-03-23 | Pyro-Sciences, Inc. | Hazardous materials incineration system |
US4468499A (en) | 1980-10-24 | 1984-08-28 | Lehigh University | Thermoplastic interpenetrating polymer network composition and process |
US4439583A (en) | 1980-11-12 | 1984-03-27 | Tyndale Plains-Hunter, Ltd. | Polyurethane diacrylate compositions useful in forming canulae |
US4452925A (en) | 1981-02-09 | 1984-06-05 | National Patent Development Corporation | Biologically stabilized compositions comprising collagen as the minor component with ethylenically unsaturated compounds used as contact lenses |
US4502161A (en) | 1981-09-21 | 1985-03-05 | Wall W H | Prosthetic meniscus for the repair of joints |
US4477604A (en) * | 1982-09-20 | 1984-10-16 | Oechsle Iii Sixtus J | Polyurethane compositions and their use as luting agents |
US4973493A (en) | 1982-09-29 | 1990-11-27 | Bio-Metric Systems, Inc. | Method of improving the biocompatibility of solid surfaces |
US4487865A (en) | 1983-12-15 | 1984-12-11 | Biomatrix, Inc. | Polymeric articles modified with hyaluronate |
US4500676A (en) | 1983-12-15 | 1985-02-19 | Biomatrix, Inc. | Hyaluronate modified polymeric articles |
US4536554A (en) | 1984-02-22 | 1985-08-20 | Barnes-Hind, Inc. | Hydrophilic polymers and contact lenses made therefrom |
US4621637A (en) * | 1984-07-30 | 1986-11-11 | Meyer Fishbein | Surgical device for removing bone and tissue from joint members |
JPS6145765A (en) | 1984-08-07 | 1986-03-05 | 宇部興産株式会社 | Blood vessel prosthesis and its production |
US4680336A (en) | 1984-11-21 | 1987-07-14 | Vistakon, Inc. | Method of forming shaped hydrogel articles |
US4966934A (en) * | 1984-11-29 | 1990-10-30 | Dentsply Research & Development Corp. | Biological compatible adhesive containing a phosphorous adhesion promoter and accelerator |
US4575539A (en) | 1985-06-03 | 1986-03-11 | E. R. Squibb & Sons, Inc. | Drug delivery systems including novel interpenetrating polymer networks and method |
WO1987005038A1 (en) | 1986-02-17 | 1987-08-27 | Commonwealth Scientific And Industrial Research Or | Implantable materials |
US4846841A (en) | 1986-04-25 | 1989-07-11 | Indong Oh | Femoral Prosthesis |
US5030230A (en) | 1986-05-16 | 1991-07-09 | Great Plains Eye Clinic, Ltd. | Corneal implant |
US4693715A (en) | 1986-06-19 | 1987-09-15 | Abel Robert Jr | Artificial cornea |
US5112350A (en) | 1986-10-16 | 1992-05-12 | Cbs Lens, A California General Partnership | Method for locating on a cornea an artificial lens fabricated from a collagen-hydrogel for promoting epithelial cell growth and regeneration of the stroma |
US5114627A (en) | 1986-10-16 | 1992-05-19 | Cbs Lens | Method for producing a collagen hydrogel |
US5290548A (en) | 1987-04-10 | 1994-03-01 | University Of Florida | Surface modified ocular implants, surgical instruments, devices, prostheses, contact lenses and the like |
US5100689A (en) | 1987-04-10 | 1992-03-31 | University Of Florida | Surface modified surgical instruments, devices, implants, contact lenses and the like |
US5094876A (en) | 1987-04-10 | 1992-03-10 | University Of Florida | Surface modified surgical instruments, devices, implants, contact lenses and the like |
US4865601A (en) | 1987-07-07 | 1989-09-12 | Caldwell Delmar R | Intraocular prostheses |
US5282851A (en) | 1987-07-07 | 1994-02-01 | Jacob Labarre Jean | Intraocular prostheses |
US5171318A (en) | 1987-11-09 | 1992-12-15 | Chiron Ophthalmics, Inc. | Treated corneal prosthetic device |
US5067961A (en) | 1988-02-18 | 1991-11-26 | Autogenesis Technologies, Inc. | Non-biodegradable two phase corneal implant and method for preparing same |
US5660692A (en) | 1988-02-24 | 1997-08-26 | Cedars-Sinai Medical Center | Method of crosslinking amino acid-containing polymers using photoactivatable chemical crosslinkers |
US5087392A (en) | 1988-05-31 | 1992-02-11 | Sola Usa, Inc. | Method of mold contact lenses |
US4931287A (en) | 1988-06-14 | 1990-06-05 | University Of Utah | Heterogeneous interpenetrating polymer networks for the controlled release of drugs |
IT215084Z2 (en) * | 1988-08-03 | 1990-07-30 | Torino A | VARIABLE EXCURSION CAMBRA |
FR2646930B1 (en) | 1989-05-12 | 1993-04-09 | Essilor Int | PROCESS FOR PRODUCING A DIFFRACTIVE ELEMENT, USABLE IN PARTICULAR IN THE MANUFACTURE OF ARTIFICIAL OPTICAL LENSES, AND LENSES THUS OBTAINED |
US4978352A (en) | 1989-06-07 | 1990-12-18 | Fedorov Svjatoslav N | Process for producing collagen-based cross-linked biopolymer, an implant from said biopolymer, method for producing said implant, and method for hermetization of corneal or scleral wounds involved in eye injuries, using said implant |
US5115056A (en) | 1989-06-20 | 1992-05-19 | Ciba-Geigy Corporation | Fluorine and/or silicone containing poly(alkylene-oxide)-block copolymers and contact lenses thereof |
US5843089A (en) | 1990-12-28 | 1998-12-01 | Boston Scientific Corporation | Stent lining |
DK0439250T3 (en) | 1990-01-25 | 1995-04-24 | Howmedica | bone Cement |
EP0454497B1 (en) | 1990-04-27 | 1997-02-26 | Nippon Shokubai Co., Ltd. | Method for production of salt-resistant absorbent resin |
US5122133A (en) * | 1990-10-26 | 1992-06-16 | Smith & Nephew Richards Inc. | Compression screw for a joint endoprosthesis |
US5133769A (en) | 1990-11-09 | 1992-07-28 | Sulzer Brothers | Cap for a femur head |
CA2101773A1 (en) | 1991-01-31 | 1992-08-01 | Toyoichi Tanaka | Interpenetrating-polymer network phase-transition gels |
JP3007903B2 (en) | 1991-03-29 | 2000-02-14 | 京セラ株式会社 | Artificial disc |
WO1993002639A1 (en) | 1991-08-06 | 1993-02-18 | Autogenesis Technologies, Inc. | Injectable collagen-based compositions for making intraocular lens |
WO1993011751A1 (en) * | 1991-12-18 | 1993-06-24 | Scimed Life Systems, Inc. | Lubricous polymer network |
US5425773A (en) | 1992-01-06 | 1995-06-20 | Danek Medical, Inc. | Intervertebral disk arthroplasty device |
DE69329594T2 (en) * | 1992-02-28 | 2001-05-31 | Univ Texas | PHOTOPOLYMERINABLE, BIODEGRADABLE HYDROGELS AS TISSUE CONTACT MATERIALS AND SUBSTANCES FOR CONTROLLED RELEASE |
US5589563A (en) | 1992-04-24 | 1996-12-31 | The Polymer Technology Group | Surface-modifying endgroups for biomedical polymers |
IT1259100B (en) * | 1992-05-20 | 1996-03-11 | Lanfranco Callegaro | USE OF HYDROGELS FOR THE LOCKING OF PROSTHETIC SYSTEMS |
IT1260154B (en) | 1992-07-03 | 1996-03-28 | Lanfranco Callegaro | HYALURONIC ACID AND ITS DERIVATIVES IN INTERPENETRATING POLYMERS (IPN) |
AU650156B2 (en) | 1992-08-05 | 1994-06-09 | Lions Eye Institute Limited | Keratoprosthesis and method of producing the same |
WO1994003129A1 (en) | 1992-08-07 | 1994-02-17 | Keravision Inc. | Hybrid intrastromal corneal ring |
EP0682503A1 (en) | 1992-10-27 | 1995-11-22 | Neoligaments Limited | Ligament graft harvesting |
US5374515A (en) | 1992-11-13 | 1994-12-20 | Organogenesis, Inc. | In vitro cornea equivalent model |
US5836313A (en) | 1993-02-08 | 1998-11-17 | Massachusetts Institute Of Technology | Methods for making composite hydrogels for corneal prostheses |
JPH06287443A (en) | 1993-04-01 | 1994-10-11 | Bando Chem Ind Ltd | Water-swelling polyurethane composition |
JP3176176B2 (en) | 1993-06-01 | 2001-06-11 | 京セラ株式会社 | Artificial cartilage and method for producing the same |
US5763529A (en) | 1994-03-31 | 1998-06-09 | Cytec Technology Corp. | Interpenetrating polymer network compositions |
US5556429A (en) | 1994-05-06 | 1996-09-17 | Advanced Bio Surfaces, Inc. | Joint resurfacing system |
US5591170A (en) * | 1994-10-14 | 1997-01-07 | Genesis Orthopedics | Intramedullary bone cutting saw |
TW325481B (en) | 1994-12-05 | 1998-01-21 | Novartis Ag | Silicon-containing polymer having oxygen permeability suitable for ophthalmic applications |
US6017577A (en) | 1995-02-01 | 2000-01-25 | Schneider (Usa) Inc. | Slippery, tenaciously adhering hydrophilic polyurethane hydrogel coatings, coated polymer substrate materials, and coated medical devices |
US5919570A (en) | 1995-02-01 | 1999-07-06 | Schneider Inc. | Slippery, tenaciously adhering hydrogel coatings containing a polyurethane-urea polymer hydrogel commingled with a poly(N-vinylpyrrolidone) polymer hydrogel, coated polymer and metal substrate materials, and coated medical devices |
US5674942A (en) | 1995-03-31 | 1997-10-07 | Johnson & Johnson Vision Products, Inc. | Interpenetrating polymer networks for contact lens production |
US5656210A (en) | 1995-03-31 | 1997-08-12 | Johnson & Johnson Vision Products, Inc. | Reaction injection molding as a process to prepare contact lenses |
US5643390A (en) | 1995-05-04 | 1997-07-01 | The University Of Delaware | Bonding techniques for high performance thermoplastic compositions |
US6027742A (en) | 1995-05-19 | 2000-02-22 | Etex Corporation | Bioresorbable ceramic composites |
JP3580611B2 (en) | 1995-09-18 | 2004-10-27 | 日本エヌエスシー株式会社 | Crosslinkable urethane-modified acrylic composite resin aqueous dispersion and method for producing the same |
RU2197501C2 (en) | 1995-11-15 | 2003-01-27 | Сейкагаку Корпорейшн | Photosolidified gel based on cross-linked hyaluronic acid and method of its preparing |
US6509098B1 (en) * | 1995-11-17 | 2003-01-21 | Massachusetts Institute Of Technology | Poly(ethylene oxide) coated surfaces |
US5976648A (en) | 1995-12-14 | 1999-11-02 | Kimberly-Clark Worldwide, Inc. | Synthesis and use of heterogeneous polymer gels |
CN1210554A (en) | 1996-02-09 | 1999-03-10 | 表面溶解实验室公司 | Water-based hydrophilic coating compositions and articles prepared therefrom |
US6005160A (en) | 1996-02-22 | 1999-12-21 | National Science Council | Heterobifunctional membrane in application of artificial cornea |
US5817704A (en) | 1996-03-08 | 1998-10-06 | The Procter & Gamble Company | Heterogeneous foam materials |
US5743918A (en) * | 1996-05-13 | 1998-04-28 | Wright Medical Technology, Inc. | Instrumentation for and method for implanting a spherical prosthesis |
FR2749753B1 (en) * | 1996-06-14 | 1998-12-24 | Mosseri Raphael | TOTAL HIP PROSTHESIS FOR ENDO-ARTICULAR PLACEMENT AND ITS ANCILLARY DEVICE |
WO1998006768A1 (en) | 1996-08-13 | 1998-02-19 | H.B. Fuller Licensing & Financing, Inc. | Water-based sulfonated polymer compositions |
US5824079A (en) | 1996-08-23 | 1998-10-20 | Drexel University | Swelling type copolymeric composite material with self-fixation characteristics |
US5800412A (en) * | 1996-10-10 | 1998-09-01 | Sts Biopolymers, Inc. | Hydrophilic coatings with hydrating agents |
US6953594B2 (en) | 1996-10-10 | 2005-10-11 | Etex Corporation | Method of preparing a poorly crystalline calcium phosphate and methods of its use |
EP1028760B1 (en) | 1996-10-15 | 2004-04-14 | Orthopaedic Hospital | Wear resistant surface-gradient cross-linked polyethylene |
ID21031A (en) | 1996-11-13 | 1999-04-08 | Menicon Co Ltd | KORNEA MADE |
AU7178698A (en) | 1996-11-15 | 1998-06-03 | Advanced Bio Surfaces, Inc. | Biomaterial system for in situ tissue repair |
US20070233269A1 (en) | 2001-05-25 | 2007-10-04 | Conformis, Inc. | Interpositional Joint Implant |
US7468075B2 (en) * | 2001-05-25 | 2008-12-23 | Conformis, Inc. | Methods and compositions for articular repair |
US7618451B2 (en) | 2001-05-25 | 2009-11-17 | Conformis, Inc. | Patient selectable joint arthroplasty devices and surgical tools facilitating increased accuracy, speed and simplicity in performing total and partial joint arthroplasty |
US8882847B2 (en) | 2001-05-25 | 2014-11-11 | Conformis, Inc. | Patient selectable knee joint arthroplasty devices |
US8545569B2 (en) | 2001-05-25 | 2013-10-01 | Conformis, Inc. | Patient selectable knee arthroplasty devices |
US5904927A (en) | 1997-03-14 | 1999-05-18 | Northeastern University | Drug delivery using pH-sensitive semi-interpenetrating network hydrogels |
US6224893B1 (en) | 1997-04-11 | 2001-05-01 | Massachusetts Institute Of Technology | Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering |
ATE201031T1 (en) | 1997-04-14 | 2001-05-15 | Degussa | METHOD FOR MODIFYING THE SURFACE OF POLYMER SUBSTRATES BY GRAFT POLYMERIZATION |
US5962005A (en) | 1997-04-17 | 1999-10-05 | Rengo Co., Ltd | Transparent cellulose hydrogel and production process thereof |
US5981826A (en) | 1997-05-05 | 1999-11-09 | Georgia Tech Research Corporation | Poly(vinyl alcohol) cryogel |
US6011082A (en) | 1997-06-02 | 2000-01-04 | Pharmacia & Upjohn Ab | Process for the modification of elastomers with surface interpreting polymer networks and elastomers formed therefrom |
US6221467B1 (en) | 1997-06-03 | 2001-04-24 | Scimed Life Systems, Inc. | Coating gradient for lubricious coatings on balloon catheters |
US6166127A (en) | 1997-06-27 | 2000-12-26 | The Sherwin-Williams Company | Interpenetrating networks of polymers |
US6171300B1 (en) * | 1997-09-04 | 2001-01-09 | Linvatec Corporation | Tubing cassette and method for cooling a surgical handpiece |
CA2227827A1 (en) | 1998-01-23 | 1999-07-23 | Unknown | In vitro artificial cornea and sclera |
KR100382568B1 (en) | 1998-02-23 | 2003-05-09 | 메사츄세츠 인스티튜트 어브 테크놀로지 | Biodegradable shape memory polymers |
AU758800B2 (en) | 1998-02-23 | 2003-03-27 | Gkss-Forschungszentrum Geesthacht Gmbh | Shape memory polymers |
US6911212B2 (en) | 1998-02-27 | 2005-06-28 | Musculoskeletal Transplant Foundation | Malleable putty and flowable paste with allograft bone having residual calcium for filling bone defects |
US6437018B1 (en) | 1998-02-27 | 2002-08-20 | Musculoskeletal Transplant Foundation | Malleable paste with high molecular weight buffered carrier for filling bone defects |
US7019192B2 (en) | 1998-02-27 | 2006-03-28 | Musculoskeletal Transplant Foundation | Composition for filling bone defects |
WO1999052571A1 (en) | 1998-04-15 | 1999-10-21 | Alcon Laboratories, Inc. | Bicomposite intraocular lens and method for its preparation |
DE19818210C5 (en) * | 1998-04-24 | 2007-02-08 | Ivoclar Vivadent Ag | Radically polymerizable dental material |
US6022925A (en) | 1998-06-23 | 2000-02-08 | The Sherwin-Williams Company | Partial interpenetrating networks of polymers |
EP1095076A4 (en) | 1998-07-08 | 2002-11-06 | Sunsoft Corp | Interpenetrating polymer network hydrophilic hydrogels for contact lens |
US6057406A (en) | 1998-08-03 | 2000-05-02 | The University Of Southern Mississippi | Functionally gradient polymeric materials |
US6630457B1 (en) | 1998-09-18 | 2003-10-07 | Orthogene Llc | Functionalized derivatives of hyaluronic acid, formation of hydrogels in situ using same, and methods for making and using same |
US20030114936A1 (en) | 1998-10-12 | 2003-06-19 | Therics, Inc. | Complex three-dimensional composite scaffold resistant to delimination |
US6331578B1 (en) | 1998-11-18 | 2001-12-18 | Josephine Turner | Process for preparing interpenetrating polymer networks of controlled morphology |
KR100306282B1 (en) | 1998-12-10 | 2001-11-02 | 윤종용 | Apparatus and for interleaving and deinterleaving frame date in communication system |
US6361560B1 (en) | 1998-12-23 | 2002-03-26 | Anamed, Inc. | Corneal implant and method of manufacture |
EP1146917A1 (en) | 1999-01-22 | 2001-10-24 | St. Jude Medical, Inc. | Medical adhesives |
US6376742B1 (en) * | 1999-02-17 | 2002-04-23 | Richard J. Zdrahala | In vivo tissue engineering with biodegradable polymers |
US6294187B1 (en) | 1999-02-23 | 2001-09-25 | Osteotech, Inc. | Load-bearing osteoimplant, method for its manufacture and method of repairing bone using same |
US6239209B1 (en) | 1999-02-23 | 2001-05-29 | Reichhold, Inc. | Air curable water-borne urethane-acrylic hybrids |
EP1166156A1 (en) | 1999-03-16 | 2002-01-02 | Zms, Llc | Precision integral articles |
US6332887B1 (en) * | 1999-04-06 | 2001-12-25 | Benjamin D. Knox | Spinal fusion instrumentation system |
US6428576B1 (en) | 1999-04-16 | 2002-08-06 | Endospine, Ltd. | System for repairing inter-vertebral discs |
US8226729B2 (en) | 2000-10-24 | 2012-07-24 | Warsaw Orthopedic, Inc. | Spinal fusion methods and devices |
US7491235B2 (en) | 1999-05-10 | 2009-02-17 | Fell Barry M | Surgically implantable knee prosthesis |
US7338524B2 (en) | 1999-05-10 | 2008-03-04 | Fell Barry M | Surgically implantable knee prosthesis |
CH694058A5 (en) | 1999-06-18 | 2004-06-30 | Woodwelding Ag | Fabric conclusive Connect. |
US6368315B1 (en) | 1999-06-23 | 2002-04-09 | Durect Corporation | Composite drug delivery catheter |
US6479565B1 (en) | 1999-08-16 | 2002-11-12 | Harold R. Stanley | Bioactive ceramic cement |
US6673079B1 (en) * | 1999-08-16 | 2004-01-06 | Washington University | Device for lengthening and reshaping bone by distraction osteogenesis |
US7008635B1 (en) | 1999-09-10 | 2006-03-07 | Genzyme Corporation | Hydrogels for orthopedic repair |
US6086204A (en) | 1999-09-20 | 2000-07-11 | Magnante; Peter C. | Methods and devices to design and fabricate surfaces on contact lenses and on corneal tissue that correct the eye's optical aberrations |
US6264695B1 (en) | 1999-09-30 | 2001-07-24 | Replication Medical, Inc. | Spinal nucleus implant |
US7687462B2 (en) | 1999-10-05 | 2010-03-30 | The Regents Of The University Of California | Composition for promoting cartilage formation or repair comprising a nell gene product and method of treating cartilage-related conditions using such composition |
US7491236B2 (en) | 2000-02-16 | 2009-02-17 | Trans1, Inc. | Dual anchor prosthetic nucleus apparatus |
US6626945B2 (en) * | 2000-03-14 | 2003-09-30 | Chondrosite, Llc | Cartilage repair plug |
US6632246B1 (en) * | 2000-03-14 | 2003-10-14 | Chondrosite, Llc | Cartilage repair plug |
EP1197782B1 (en) * | 2000-03-22 | 2004-06-02 | Menicon Co., Ltd. | Material for ocular lens |
US9314339B2 (en) | 2000-03-27 | 2016-04-19 | Formae, Inc. | Implants for replacing cartilage, with negatively-charged hydrogel surfaces and flexible matrix reinforcement |
US6629997B2 (en) | 2000-03-27 | 2003-10-07 | Kevin A. Mansmann | Meniscus-type implant with hydrogel surface reinforced by three-dimensional mesh |
US6689165B2 (en) | 2000-03-31 | 2004-02-10 | Board Of Supervisors Of Louisana State University And Agricultural And Mechanical College | Surface modifications for enhanced epithelialization |
US6254637B1 (en) | 2000-04-10 | 2001-07-03 | Lucid Korea Co., Ltd. | Artificial cornea and implantation thereof |
US6846875B2 (en) | 2000-04-10 | 2005-01-25 | Pharmacia Groningen Bv | Hydrogels and methods for their production |
US6372815B1 (en) | 2000-04-18 | 2002-04-16 | Ocular Sciences Inc | Ophthalmic lenses and compositions, and methods for producing same |
US6679917B2 (en) * | 2000-05-01 | 2004-01-20 | Arthrosurface, Incorporated | System and method for joint resurface repair |
US6610067B2 (en) * | 2000-05-01 | 2003-08-26 | Arthrosurface, Incorporated | System and method for joint resurface repair |
US6520964B2 (en) * | 2000-05-01 | 2003-02-18 | Std Manufacturing, Inc. | System and method for joint resurface repair |
US7163541B2 (en) | 2002-12-03 | 2007-01-16 | Arthrosurface Incorporated | Tibial resurfacing system |
US7678151B2 (en) * | 2000-05-01 | 2010-03-16 | Ek Steven W | System and method for joint resurface repair |
US20040230315A1 (en) | 2000-05-01 | 2004-11-18 | Ek Steven W. | Articular surface implant |
US7713305B2 (en) * | 2000-05-01 | 2010-05-11 | Arthrosurface, Inc. | Articular surface implant |
US7618462B2 (en) * | 2000-05-01 | 2009-11-17 | Arthrosurface Incorporated | System and method for joint resurface repair |
EP1315470B1 (en) | 2000-08-28 | 2009-07-15 | Disc Dynamics, Inc. | System for mammalian joint resurfacing |
US6726322B2 (en) | 2000-09-28 | 2004-04-27 | Novartis Ag | Fenestrated lens for increased tear flow and method of making the same |
US6524327B1 (en) | 2000-09-29 | 2003-02-25 | Praxis, Llc | In-situ bonds |
JP2004515311A (en) | 2000-10-25 | 2004-05-27 | エスディージーアイ・ホールディングス・インコーポレーテッド | Vertically expanding intervertebral fusion device |
US6692528B2 (en) * | 2000-11-09 | 2004-02-17 | The Polymer Technology Group Incorporated | Devices that change size/shape via osmotic pressure |
GB0100199D0 (en) | 2001-01-05 | 2001-02-14 | Mcminn Derek J W | Hip prosthesis |
DE10103784C1 (en) | 2001-01-29 | 2002-10-10 | Rodenstock Optik G | Photochromic plastic object |
US9050192B2 (en) * | 2001-02-05 | 2015-06-09 | Formae, Inc. | Cartilage repair implant with soft bearing surface and flexible anchoring device |
CN1162187C (en) | 2001-02-22 | 2004-08-18 | 华东理工大学 | Inorganic bane adhesive and its application in body's hard tissue repair |
DE50208067D1 (en) | 2001-03-02 | 2006-10-19 | Woodwelding Ag | Implants and device for connecting tissue parts |
US6949251B2 (en) | 2001-03-02 | 2005-09-27 | Stryker Corporation | Porous β-tricalcium phosphate granules for regeneration of bone tissue |
US6632235B2 (en) | 2001-04-19 | 2003-10-14 | Synthes (U.S.A.) | Inflatable device and method for reducing fractures in bone and in treating the spine |
AU2002258913A1 (en) * | 2001-04-23 | 2002-11-05 | Wisconsin Alumni Research Foundation | Bifunctional-modified hydrogels |
US8728445B2 (en) | 2001-05-01 | 2014-05-20 | A.V. Topchiev Institute Of Petrochemical Synthesis, Russian Academy Of Sciences | Hydrogel Compositions |
KR100404839B1 (en) * | 2001-05-15 | 2003-11-07 | 엘지전자 주식회사 | Addressing Method and Apparatus of Plasma Display Panel |
US6482209B1 (en) * | 2001-06-14 | 2002-11-19 | Gerard A. Engh | Apparatus and method for sculpting the surface of a joint |
US6844028B2 (en) | 2001-06-26 | 2005-01-18 | Accelr8 Technology Corporation | Functional surface coating |
US20040266941A1 (en) | 2001-06-27 | 2004-12-30 | Houston Michael R. | Biomedical molding materials from semi-solid precursors |
US6747090B2 (en) | 2001-07-16 | 2004-06-08 | Pharmacia Groningen Bv | Compositions capable of forming hydrogels in the eye |
US6541281B2 (en) | 2001-07-16 | 2003-04-01 | Tachyon Semiconductors Corporation | Ferroelectric circuit element that can be fabricated at low temperatures and method for making the same |
US6755865B2 (en) * | 2001-09-24 | 2004-06-29 | Imad Ed. Tarabishy | Joint prosthesis and method for placement |
DE10150737A1 (en) | 2001-10-15 | 2003-04-30 | Hilti Ag | Multi-component foam system and its use |
JP4095794B2 (en) | 2001-12-03 | 2008-06-04 | 日東電工株式会社 | Composite film and semiconductor product holding sheet |
US20030130741A1 (en) * | 2002-01-07 | 2003-07-10 | Mcminn Derek James Wallace | Hip prosthesis |
US20040147466A1 (en) | 2002-01-17 | 2004-07-29 | Barman Shikha P. | Nucleic acid delivery formulations |
US7458991B2 (en) * | 2002-02-08 | 2008-12-02 | Howmedica Osteonics Corp. | Porous metallic scaffold for tissue ingrowth |
US7559928B2 (en) * | 2002-02-12 | 2009-07-14 | Alexandria Research Technologies, Llc | Apparatus and method for minimally invasive total joint replacement |
CA2476315A1 (en) | 2002-02-15 | 2003-08-28 | Zms, Llc | Polymerization process and materials for biomedical applications |
DE60323943D1 (en) | 2002-02-21 | 2008-11-20 | Encelle Inc | IMMOBILIZED BIOACTIVE HYDROGEL MATRICES FOR SURFACE COATINGS |
US6955716B2 (en) | 2002-03-01 | 2005-10-18 | American Dental Association Foundation | Self-hardening calcium phosphate materials with high resistance to fracture, controlled strength histories and tailored macropore formation rates |
US7468192B2 (en) | 2002-03-22 | 2008-12-23 | Histogenics Corporation | Method for repair of cartilage lesions |
AU2003220895A1 (en) * | 2002-03-28 | 2003-10-13 | Sun Medical Co., Ltd. | Paste polymerization initiator composition, dental or surgical adhesive and adhesive kit |
CA2480141A1 (en) | 2002-03-28 | 2003-10-09 | Exponential Biotherapies, Inc. | Oxygenating agents for enhancing host responses to microbial infections |
DE10217351B3 (en) | 2002-04-18 | 2004-02-12 | Mnemoscience Gmbh | Interpenetrating networks |
WO2003089506A1 (en) | 2002-04-22 | 2003-10-30 | Purdue Research Foundation | Hydrogels having enhanced elasticity and mechanical strength properties |
AU2002309026A1 (en) | 2002-05-01 | 2003-11-17 | Hokkaido Technology Licensing Office Co., Ltd. | Gel having multiple network structure and method for preparation thereof |
US7235102B2 (en) | 2002-05-10 | 2007-06-26 | Ferree Bret A | Prosthetic components with contained compressible resilient members |
US7066958B2 (en) | 2002-05-10 | 2006-06-27 | Ferree Bret A | Prosthetic components with partially contained compressible resilient members |
CA2485338A1 (en) | 2002-06-18 | 2003-12-24 | Jaan Noolandi | Artificial cornea |
US7476398B1 (en) | 2002-06-28 | 2009-01-13 | Universite Laval | Corneal implant and uses thereof |
ES2309350T3 (en) | 2002-07-11 | 2008-12-16 | Advanced Bio Surfaces, Inc. | METHOD AND EQUIPMENT FOR INTERPOSITIONAL ARTROPLASTY. |
US7745532B2 (en) | 2002-08-02 | 2010-06-29 | Cambridge Polymer Group, Inc. | Systems and methods for controlling and forming polymer gels |
EP1545798A4 (en) | 2002-08-02 | 2006-06-14 | Us Gov Health & Human Serv | Cross-linked nitric oxide-releasing polyamine coated substrates, compositions comprising same and method of making same |
US7485670B2 (en) | 2002-08-02 | 2009-02-03 | Cambridge Polymer Group, Inc. | Systems and methods for controlling and forming polymer gels |
US20040028804A1 (en) | 2002-08-07 | 2004-02-12 | Anderson Daniel G. | Production of polymeric microarrays |
US7959636B2 (en) | 2002-08-15 | 2011-06-14 | Arthrex, Inc. | Osteochondral repair using plug fashioned from whole distal femur or condyle formed of hydrogel composition |
US7008226B2 (en) | 2002-08-23 | 2006-03-07 | Woodwelding Ag | Implant, in particular a dental implant |
US6955540B2 (en) | 2002-08-23 | 2005-10-18 | Woodwelding Ag | Preparation for being fastened on a natural tooth part or tooth and corresponding fastening method |
US6984700B2 (en) * | 2002-09-17 | 2006-01-10 | Medtronic, Inc. | Compounds containing silicon-containing groups, medical devices, and methods |
US7264634B2 (en) | 2002-09-20 | 2007-09-04 | Arthrex, Inc. | Method and instrumentation for osteochondral repair using preformed implants |
US8673333B2 (en) | 2002-09-25 | 2014-03-18 | The Johns Hopkins University | Cross-linked polymer matrices, and methods of making and using same |
US6918914B2 (en) * | 2002-10-10 | 2005-07-19 | Clayton T. Bauer | Minimally invasive adjustable acetubular reamer |
US7049351B2 (en) | 2002-11-01 | 2006-05-23 | Novartis Ag | Moldings and preparation and uses thereof |
EP1558181B1 (en) | 2002-11-07 | 2015-08-26 | ConforMIS, Inc. | Methods for determining meniscal size and shape and for devising treatment |
US6896965B1 (en) | 2002-11-12 | 2005-05-24 | Advanced Cardiovascular Systems, Inc. | Rate limiting barriers for implantable devices |
US6733533B1 (en) * | 2002-11-19 | 2004-05-11 | Zimmer Technology, Inc. | Artificial spinal disc |
US20040102852A1 (en) | 2002-11-22 | 2004-05-27 | Johnson Erin M. | Modular knee prosthesis |
US20040116564A1 (en) | 2002-11-27 | 2004-06-17 | Devlin Brian Gerrard | Stabilization of poly(oxyalkylene) containing polymeric materials |
US20050251267A1 (en) * | 2004-05-04 | 2005-11-10 | John Winterbottom | Cell permeable structural implant |
US20060127878A1 (en) | 2002-12-18 | 2006-06-15 | Salomon David H | Hydrogel preparation and process of manufacture thereof |
US20050013793A1 (en) * | 2003-01-16 | 2005-01-20 | Beckman Eric J. | Biodegradable polyurethanes and use thereof |
US6994730B2 (en) | 2003-01-31 | 2006-02-07 | Howmedica Osteonics Corp. | Meniscal and tibial implants |
GB2397766A (en) * | 2003-02-03 | 2004-08-04 | Univ London | A Surgical Kit For Hemiarthroplasty Hip Replacement |
US20040153040A1 (en) * | 2003-02-05 | 2004-08-05 | Lucie Martineau | Multi-layer synthetic dressing with cooling characteristics |
US20040230309A1 (en) | 2003-02-14 | 2004-11-18 | Depuy Spine, Inc. | In-situ formed intervertebral fusion device and method |
US7097646B2 (en) * | 2003-02-21 | 2006-08-29 | Zimmer Inc. | Collapsible acetabular reamer |
US7563483B2 (en) * | 2003-02-26 | 2009-07-21 | Advanced Cardiovascular Systems Inc. | Methods for fabricating a coating for implantable medical devices |
US7160305B2 (en) | 2003-03-07 | 2007-01-09 | Arthrex, Inc. | Retrodrill technique for insertion of autograft, allograft or synthetic osteochondral implants |
WO2004089624A2 (en) | 2003-04-11 | 2004-10-21 | Csir | Packaging with water soluble barrier layer |
IES20030294A2 (en) | 2003-04-17 | 2004-10-20 | Medtronic Vascular Connaught | Coating for biomedical devices |
ES2634840T5 (en) | 2003-04-24 | 2022-12-22 | Coopervision Int Ltd | Hydrogel contact lenses and packaging systems and production methods thereof |
US7279174B2 (en) * | 2003-05-08 | 2007-10-09 | Advanced Cardiovascular Systems, Inc. | Stent coatings comprising hydrophilic additives |
US7488348B2 (en) | 2003-05-16 | 2009-02-10 | Musculoskeletal Transplant Foundation | Cartilage allograft plug |
US7758497B2 (en) | 2003-06-20 | 2010-07-20 | Contura A/S | Endoscopic attachment device |
US6974862B2 (en) * | 2003-06-20 | 2005-12-13 | Kensey Nash Corporation | High density fibrous polymers suitable for implant |
US20070067032A1 (en) | 2003-06-27 | 2007-03-22 | Felt Jeffrey C | Meniscus preserving implant method and apparatus |
US7176247B1 (en) | 2003-06-27 | 2007-02-13 | The United States Of America As Represented By The Secretary Of The Army | Interpenetrating polymer network |
US7582698B2 (en) | 2003-07-02 | 2009-09-01 | Lubrizol Advanced Materials, Inc. | Water dispersions of non-uniform polyurethane particles |
WO2005009256A2 (en) | 2003-07-31 | 2005-02-03 | Woodwelding Ag | Method and device for promotion of tissue regeneration on wound surfaces |
US7153325B2 (en) * | 2003-08-01 | 2006-12-26 | Ultra-Kinetics, Inc. | Prosthetic intervertebral disc and methods for using the same |
US7794476B2 (en) | 2003-08-08 | 2010-09-14 | Warsaw Orthopedic, Inc. | Implants formed of shape memory polymeric material for spinal fixation |
WO2005014073A1 (en) | 2003-08-08 | 2005-02-17 | Contura Sa | Implantable hydrogel with resorbable shell for use as an endoprothesis |
US10583220B2 (en) | 2003-08-11 | 2020-03-10 | DePuy Synthes Products, Inc. | Method and apparatus for resurfacing an articular surface |
US7217294B2 (en) | 2003-08-20 | 2007-05-15 | Histogenics Corp. | Acellular matrix implants for treatment of articular cartilage, bone or osteochondral defects and injuries and method for use thereof |
US20050054774A1 (en) | 2003-09-09 | 2005-03-10 | Scimed Life Systems, Inc. | Lubricious coating |
US7544381B2 (en) | 2003-09-09 | 2009-06-09 | Boston Scientific Scimed, Inc. | Lubricious coatings for medical device |
EP1687043A2 (en) * | 2003-11-20 | 2006-08-09 | Angiotech International Ag | Electrical devices and anti-scarring agents |
US20050113836A1 (en) * | 2003-11-25 | 2005-05-26 | Lozier Antony J. | Expandable reamer |
WO2005062868A2 (en) | 2003-12-19 | 2005-07-14 | Osteotech, Inc. | Tissue-derived mesh for orthopedic regeneration |
US7842667B2 (en) | 2003-12-22 | 2010-11-30 | Regentis Biomaterials Ltd. | Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same |
US20050171604A1 (en) | 2004-01-20 | 2005-08-04 | Alexander Michalow | Unicondylar knee implant |
ES2565664T3 (en) | 2004-02-20 | 2016-04-06 | Woodwelding Ag | Implant to implant in bone tissue and procedure for its manufacture |
US7709439B2 (en) * | 2004-02-20 | 2010-05-04 | Boston Scientific Scimed, Inc. | Biomaterials for enhanced healing |
US20070100457A1 (en) | 2004-03-04 | 2007-05-03 | Hyde Edward R Jr | Paramagnetic liquid interface |
GB0405059D0 (en) * | 2004-03-05 | 2004-04-07 | Benoist Girard Sas | Prosthetic acetabular cup inserter |
WO2005087191A1 (en) * | 2004-03-09 | 2005-09-22 | Interpolymer Corporation | Personal care fixative |
US20050218541A1 (en) * | 2004-04-02 | 2005-10-06 | Peng Henry T | Method of producing interpenetrating polymer network |
US8657881B2 (en) | 2004-04-20 | 2014-02-25 | Depuy Mitek, Llc | Meniscal repair scaffold |
US20050267482A1 (en) * | 2004-04-22 | 2005-12-01 | Hyde Edward R Jr | Bone treatment method with implants and instrumentation |
US20050256576A1 (en) | 2004-05-13 | 2005-11-17 | Moskowitz Nathan C | Artificial expansile total lumbar and thoracic discs for posterior placement without supplemental instrumentation and its adaptation for anterior placement of artificial cervical, thoracic and lumbar discs |
US20050278025A1 (en) | 2004-06-10 | 2005-12-15 | Salumedica Llc | Meniscus prosthesis |
WO2006013612A1 (en) | 2004-06-18 | 2006-02-09 | Hokkaido Technology Licensing Office Co., Ltd. | Artificial semilunar cartilage |
DE102004042183A1 (en) * | 2004-06-22 | 2006-01-19 | Plus Endoprothetik Ag | Device for setting or removing joints or joint sockets |
EP1611877A1 (en) | 2004-06-28 | 2006-01-04 | Universidade de Coimbra | Method for preparing sustained-release therapeutic ophthalmic articles using compressed fluids for impregnation of drugs |
EP1627615A3 (en) | 2004-08-18 | 2006-11-02 | Arthrex, Inc. | Modular joint replacement implant with hydrogel surface |
US7909867B2 (en) | 2004-10-05 | 2011-03-22 | The Board Of Trustees Of The Leland Stanford Junior University | Interpenetrating polymer network hydrogel corneal prosthesis |
US7857849B2 (en) | 2004-10-05 | 2010-12-28 | The Board Of Trustees Of The Leland Stanford Junior Iniversity | Artificial corneal implant |
US7857447B2 (en) * | 2004-10-05 | 2010-12-28 | The Board Of Trustees Of The Leland Stanford Junior University | Interpenetrating polymer network hydrogel contact lenses |
US8821583B2 (en) * | 2004-10-05 | 2014-09-02 | The Board Of Trustees Of The Leland Stanford Junior University | Interpenetrating polymer network hydrogel |
US20060287721A1 (en) | 2004-10-05 | 2006-12-21 | David Myung | Artificial cornea |
US7235592B2 (en) | 2004-10-12 | 2007-06-26 | Zimmer Gmbh | PVA hydrogel |
FR2876278B1 (en) * | 2004-10-13 | 2007-10-26 | Thomas Gradel | COTYL APPLICATION INSTRUMENTS |
US20060282169A1 (en) | 2004-12-17 | 2006-12-14 | Felt Jeffrey C | System and method for upper extremity joint arthroplasty |
DE102004062225A1 (en) | 2004-12-23 | 2006-07-06 | Hilti Ag | Multi-component foam system for the production of interpenetrating polymeric networks and its use |
TW200640061A (en) | 2005-01-04 | 2006-11-16 | Hitachi Chemical Co Ltd | Phase separation type polymer electrolyte film, electrode/phase separation type polymer electrolyte film assembly employing the same, processes for producing the same, and fuel cell employing the same |
WO2006091530A2 (en) | 2005-02-22 | 2006-08-31 | Transform Pharmaceuticals, Inc. | Combinatorial hydrogel formulation |
CA2591921A1 (en) | 2005-02-23 | 2006-08-31 | Zimmer Technology, Inc. | Blend hydrogels and methods of making |
US20060224244A1 (en) | 2005-03-31 | 2006-10-05 | Zimmer Technology, Inc. | Hydrogel implant |
US20060235542A1 (en) | 2005-04-15 | 2006-10-19 | Zimmer Technology, Inc. | Flexible segmented bearing implant |
US7291169B2 (en) | 2005-04-15 | 2007-11-06 | Zimmer Technology, Inc. | Cartilage implant |
US7182783B2 (en) | 2005-04-25 | 2007-02-27 | Sdgi Holdings, Inc. | Selectively expandable composite structures for spinal arthroplasty |
US20060241759A1 (en) | 2005-04-25 | 2006-10-26 | Sdgi Holdings, Inc. | Oriented polymeric spinal implants |
US7722615B2 (en) | 2005-05-24 | 2010-05-25 | Gary Botimer | Expandable surgical reaming tool |
US7547319B2 (en) * | 2005-06-15 | 2009-06-16 | Ouroboros Medical | Mechanical apparatus and method for artificial disc replacement |
GB0514076D0 (en) * | 2005-07-08 | 2005-08-17 | Depuy Int Ltd | Bioactive bone cement composition |
US7959681B2 (en) * | 2005-08-22 | 2011-06-14 | Vilex In Tennessee, Inc. | Cannulated hemi-implant and methods of use thereof |
US7651701B2 (en) | 2005-08-29 | 2010-01-26 | Sanatis Gmbh | Bone cement composition and method of making the same |
US8420605B2 (en) | 2005-09-07 | 2013-04-16 | The University Of Strathclyde | Hydrogel compositions |
AU2006289625B2 (en) | 2005-09-09 | 2013-08-29 | Ottawa Health Research Institute | Interpenetrating networks, and related methods and compositions |
US20070088444A1 (en) | 2005-10-13 | 2007-04-19 | Robert A Hodorek | Method for repairing a bone defect using a formable implant which hardens in vivo |
EP1951158A4 (en) | 2005-11-21 | 2010-03-31 | Vertegen Inc | Devices and methods for treating facet joints, uncovertebral joints, costovertebral joints and other joints |
US20070118218A1 (en) | 2005-11-22 | 2007-05-24 | Hooper David M | Facet joint implant and procedure |
CA2632120C (en) | 2005-12-07 | 2014-07-08 | Zimmer, Inc. | Methods of bonding or modifying hydrogels using irradiation |
US20070141108A1 (en) | 2005-12-20 | 2007-06-21 | Zimmer, Inc. | Fiber-reinforced water-swellable articles |
EP1976460A4 (en) * | 2006-01-19 | 2012-06-20 | Warsaw Orthopedic Inc | Injectable and moldable bone substitute materials |
US8038920B2 (en) | 2006-01-25 | 2011-10-18 | Carticept Medical, Inc. | Methods of producing PVA hydrogel implants and related devices |
US20070179607A1 (en) | 2006-01-31 | 2007-08-02 | Zimmer Technology, Inc. | Cartilage resurfacing implant |
CN105030296A (en) | 2006-02-06 | 2015-11-11 | 康复米斯公司 | Patient selectable joint arthroplasty devices and surgical tools |
US8858632B2 (en) | 2006-03-23 | 2014-10-14 | Formae, Inc. | Implants for replacing hyaline cartilage, with hydrogel reinforced by three-dimensional fiber arrays |
US8110242B2 (en) | 2006-03-24 | 2012-02-07 | Zimmer, Inc. | Methods of preparing hydrogel coatings |
US9017380B2 (en) | 2006-04-03 | 2015-04-28 | Woodwelding Ag | Surgical method, kit of parts, and implant |
US20080058954A1 (en) * | 2006-08-22 | 2008-03-06 | Hai Trieu | Methods of treating spinal injuries using injectable flowable compositions comprising organic materials |
US20080103505A1 (en) | 2006-10-26 | 2008-05-01 | Hendrik Raoul Andre Fransen | Containment device for site-specific delivery of a therapeutic material and methods of use |
CA2914805C (en) | 2006-11-06 | 2017-12-12 | Novartis Ag | Ocular devices and methods of making and using thereof |
US8334044B2 (en) | 2007-02-06 | 2012-12-18 | The Board Of Trustees Of The Leland Stanford Junior University | Hydrogel-metal assembly |
US7731988B2 (en) | 2007-08-03 | 2010-06-08 | Zimmer, Inc. | Multi-polymer hydrogels |
WO2009032071A2 (en) | 2007-08-29 | 2009-03-12 | Spinemedica Corporation | Orthopaedic cement mixtures with low weight percent polyvinyl alcohol (pva) solution |
US8062739B2 (en) | 2007-08-31 | 2011-11-22 | Zimmer, Inc. | Hydrogels with gradient |
WO2009070429A1 (en) | 2007-11-29 | 2009-06-04 | Bausch & Lomb Incorporated | Process for making biomedical devices |
US20090176891A1 (en) * | 2007-12-06 | 2009-07-09 | Sami Chogle | Dental composition and method of use |
GB0724020D0 (en) | 2007-12-08 | 2008-01-23 | Depuy Int Ltd | An instrument |
EP2231230A4 (en) | 2007-12-21 | 2013-01-23 | Carticept Medical Inc | Articular injection system |
GB0803041D0 (en) * | 2008-02-20 | 2008-03-26 | Depuy Int Ltd | Surgical instrument |
US20090233887A1 (en) * | 2008-03-12 | 2009-09-17 | Shalaby Shalaby W | Hydroswellable, Segmented, Aliphatic Polyurethanes and Polyurethane Ureas |
US20100056646A1 (en) * | 2008-03-12 | 2010-03-04 | Shalaby Shalaby W | Hydroswellable, segmented, aliphatic polyurethane ureas and intra-articular devices therefrom |
US20090240337A1 (en) * | 2008-03-21 | 2009-09-24 | David Myung | Methods, Devices and Compositions for Adhering Hydrated Polymer Implants to Bone |
GB2460939B (en) | 2008-06-13 | 2010-07-21 | Foundry Llc | Methods and apparatus for joint distraction |
AU2009268687A1 (en) | 2008-07-07 | 2010-01-14 | Biomimedica, Inc | Hydrophilic interpenetrating polymer networks derived from hydrophobic polymers |
US20120209396A1 (en) | 2008-07-07 | 2012-08-16 | David Myung | Orthopedic implants having gradient polymer alloys |
DE102008049661A1 (en) | 2008-09-30 | 2010-04-01 | Smith & Nephew Orthopaedics Ag | Instrument for handling a joint component |
US10258473B2 (en) * | 2008-11-19 | 2019-04-16 | Softjoint Corporation | Device and method for restoring joints with artificial cartilage |
EP2451396B1 (en) | 2009-07-10 | 2016-06-08 | Kirk Promotion LTD. | Hip joint device |
WO2011075742A1 (en) | 2009-12-18 | 2011-06-23 | Biomimedica, Inc. | Method, device, and system for shaving and shaping of a joint |
EP2609154B1 (en) * | 2010-08-27 | 2020-04-22 | Hyalex Orthopaedics, Inc. | Hydrophobic and hydrophilic interpenetrating polymer networks derived from hydrophobic polymers and methods of preparing the same |
WO2013052105A2 (en) | 2011-10-03 | 2013-04-11 | Biomimedica, Inc. | Polymeric adhesive for anchoring compliant materials to another surface |
WO2013078284A1 (en) | 2011-11-21 | 2013-05-30 | Biomimedica, Inc. | Systems, devices, and methods for anchoring orthopaedic implants to bone |
-
2009
- 2009-08-05 US US12/536,233 patent/US8497023B2/en not_active Expired - Fee Related
- 2009-08-05 KR KR1020117005092A patent/KR20110040969A/en not_active Application Discontinuation
- 2009-08-05 WO PCT/US2009/052828 patent/WO2010017282A1/en active Application Filing
- 2009-08-05 EP EP09805493.5A patent/EP2323670A4/en not_active Withdrawn
- 2009-08-05 AU AU2009279716A patent/AU2009279716A1/en not_active Abandoned
- 2009-08-05 JP JP2011522212A patent/JP5722773B2/en not_active Expired - Fee Related
- 2009-08-05 CA CA2731698A patent/CA2731698A1/en not_active Abandoned
-
2013
- 2013-05-29 US US13/905,028 patent/US8853294B2/en not_active Expired - Fee Related
-
2014
- 2014-04-02 US US14/243,843 patent/US20140213661A1/en not_active Abandoned
- 2014-10-07 US US14/508,895 patent/US20150025161A1/en not_active Abandoned
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4423099A (en) * | 1980-07-28 | 1983-12-27 | Ciba-Geigy Corporation | Membrane modified hydrogels |
US5091205A (en) * | 1989-01-17 | 1992-02-25 | Union Carbide Chemicals & Plastics Technology Corporation | Hydrophilic lubricious coatings |
US5576072A (en) * | 1995-02-01 | 1996-11-19 | Schneider (Usa), Inc. | Process for producing slippery, tenaciously adhering hydrogel coatings containing a polyurethane-urea polymer hydrogel commingled with at least one other, dissimilar polymer hydrogel |
US7220491B2 (en) * | 2002-12-19 | 2007-05-22 | Kimberly-Clark Worldwide, Inc. | Lubricious coating for medical devices |
US20050287187A1 (en) * | 2003-10-02 | 2005-12-29 | Mansmann Kevin A | Hydrogel implants for replacing hyaline cartilage, with charged surfaces and improved anchoring |
US20090088846A1 (en) * | 2007-04-17 | 2009-04-02 | David Myung | Hydrogel arthroplasty device |
US8497023B2 (en) * | 2008-08-05 | 2013-07-30 | Biomimedica, Inc. | Polyurethane-grafted hydrogels |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2017007100A (en) * | 2015-06-16 | 2017-01-12 | 株式会社春日井化成工業所 | Production method for urethane-based molding |
US11116702B2 (en) * | 2016-12-14 | 2021-09-14 | Dentsply Sirona Inc. | Dental composition |
Also Published As
Publication number | Publication date |
---|---|
JP2011530336A (en) | 2011-12-22 |
EP2323670A4 (en) | 2013-12-25 |
US20130261212A1 (en) | 2013-10-03 |
CA2731698A1 (en) | 2010-02-11 |
WO2010017282A1 (en) | 2010-02-11 |
US20100032090A1 (en) | 2010-02-11 |
EP2323670A1 (en) | 2011-05-25 |
US8853294B2 (en) | 2014-10-07 |
US8497023B2 (en) | 2013-07-30 |
US20150025161A1 (en) | 2015-01-22 |
KR20110040969A (en) | 2011-04-20 |
AU2009279716A1 (en) | 2010-02-11 |
JP5722773B2 (en) | 2015-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8853294B2 (en) | Polyurethane-grafted hydrogels | |
US10752768B2 (en) | Orthopedic implants having gradient polymer alloys | |
US8883915B2 (en) | Hydrophobic and hydrophilic interpenetrating polymer networks derived from hydrophobic polymers and methods of preparing the same | |
EP2297217B1 (en) | Hydrophilic interpenetrating polymer networks derived from hydrophobic polymers | |
JP2019005624A (en) | Orthopedic implants having gradient polymer alloys | |
US20190218386A1 (en) | Ionic polymer compositions | |
Alves et al. | Biomedical polyurethanes-based materials |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |